{"content":"<li class=\"n-box-item date-title\" data-end=\"1529985599\" data-start=\"1529899200\" data-txt=\"Monday, December 23, 2019\">Monday, June 25, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3366144\" data-ts=\"1529970799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCG\" target=\"_blank\">SCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366144-dow-utilities-cap-best-eight-day-stretch-in-two-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dow utilities cap best eight-day stretch in more than two years</a></h4><ul>     <li>The utilities sector provided an island of prosperity amid an ocean of losses in today's trade, <a href=\"https://www.marketwatch.com/story/dow-utilities-rally-head-for-best-8-day-stretch-in-over-two-years-2018-06-25?yptr=yahoo\" target=\"_blank\">rallying to a two-month high</a> and its best eight-session stretch in more than two years.</li>     <li>The Dow Jones utilities index has climbed 6.3% during the streak in the best eight-day percentage gain since rallying 6.5% during an eight-day stretch that ended in February 2016.</li><li>In today's trade: <a href='https://seekingalpha.com/symbol/SCG' title='SCANA Corporation'>SCG</a> <font color='green'>+3.7%</font>, <a href='https://seekingalpha.com/symbol/FE' title='FirstEnergy Corp'>FE</a> <font color='green'>+3.1%</font>, <a href='https://seekingalpha.com/symbol/AEP' title='American Electric Power Company Inc'>AEP</a> <font color='green'>+2.5%</font>, <a href='https://seekingalpha.com/symbol/NI' title='NiSource Inc.'>NI</a> <font color='green'>+2.4%</font>, <a href='https://seekingalpha.com/symbol/DTE' title='DTE Energy Company'>DTE</a> <font color='green'>+2.3%</font>, <a href='https://seekingalpha.com/symbol/ED' title='Consolidated Edison Inc.'>ED</a> <font color='green'>+2.2%</font>, <a href='https://seekingalpha.com/symbol/DUK' title='Duke Energy Corporation'>DUK</a> <font color='green'>+2.1%</font>, <a href='https://seekingalpha.com/symbol/PPL' title='PPL Corporation'>PPL</a> <font color='green'>+1.9%</font>, <a href='https://seekingalpha.com/symbol/WEC' title='WEC Energy Group, Inc.'>WEC</a> <font color='green'>+1.8%</font>, <a href='https://seekingalpha.com/symbol/SO' title='Southern Company'>SO</a> <font color='green'>+1.7%</font>, <a href='https://seekingalpha.com/symbol/PEG' title='Public Service Enterprise Group Inc.'>PEG</a> <font color='green'>+1.7%</font>, <a href='https://seekingalpha.com/symbol/AEE' title='Ameren Corporation'>AEE</a> <font color='green'>+1.6%</font>, <a href='https://seekingalpha.com/symbol/D' title='Dominion Energy, Inc.'>D</a> <font color='green'>+1.4%</font>, <a href='https://seekingalpha.com/symbol/NEE' title='NextEra Energy, Inc.'>NEE</a> <font color='green'>+1.3%</font>, <a href='https://seekingalpha.com/symbol/SRE' title='Sempra Energy'>SRE</a> <font color='green'>+1.3%</font>, <a href='https://seekingalpha.com/symbol/ETR' title='Entergy Corporation'>ETR</a> <font color='green'>+1%</font>, <a href='https://seekingalpha.com/symbol/EIX' title='Edison International'>EIX</a> <font color='green'>+1%</font>, <a href='https://seekingalpha.com/symbol/EXC' title='Exelon Corporation'>EXC</a> <font color='green'>+0.8%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLU' title='Utilities Select Sector SPDR ETF'>XLU</a>, <a href='https://seekingalpha.com/symbol/UTG' title='Reaves Utility Income Fund'>UTG</a>, <a href='https://seekingalpha.com/symbol/VPU' title='Vanguard Utilities ETF'>VPU</a>, <a href='https://seekingalpha.com/symbol/GUT' title='Gabelli Utility Trust'>GUT</a>, <a href='https://seekingalpha.com/symbol/IDU' title='iShares U.S. Utilities ETF'>IDU</a>, <a href='https://seekingalpha.com/symbol/BUI' title='BlackRock Utility&Infrastructure Trust'>BUI</a>, <a href='https://seekingalpha.com/symbol/FUTY' title='Fidelity MSCI Utilities Index ETF'>FUTY</a>, <a href='https://seekingalpha.com/symbol/RYU' title='Invesco S&P Equal Weight Utilities ETF'>RYU</a>, <a href='https://seekingalpha.com/symbol/UPW' title='ProShares Ultra Utilities ETF'>UPW</a>, <a href='https://seekingalpha.com/symbol/PSCU' title='Invesco S&P SmallCap Utilities Portfolio ETF'>PSCU</a>, <a href='https://seekingalpha.com/symbol/FXU' title='First Trust Utilities AlphaDEX ETF'>FXU</a>, <a href='https://seekingalpha.com/symbol/SDP' title='ProShares UltraShort Utilities ETF'>SDP</a>, <a href='https://seekingalpha.com/symbol/PUI' title='Invesco DWA Utilities Momentum Portfolio ETF'>PUI</a>, <a href='https://seekingalpha.com/symbol/FUGAX' title='Fidelity AdvisorÂ® Utilities Fund A'>FUGAX</a>, <a href='https://seekingalpha.com/symbol/JHMU' title='John Hancock Multifactor Utilities ETF'>JHMU</a>, <a href='https://seekingalpha.com/symbol/BUYN' title='USCF SummerHaven SHPEN Index Fund'>BUYN</a>, <a href='https://seekingalpha.com/symbol/UTLF' title='iShares Edge MSCI Multifactor Utilities ETF'>UTLF</a>, <a href='https://seekingalpha.com/symbol/XU' title='Elkhorn S&P MidCap Utilities ETF'>XU</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3366144\" data-linked=\"Dow utilities cap best eight-day stretch in more than two years\" data-tweet=\"$SCG $SCG $FE - Dow utilities cap best eight-day stretch in more than two years https://seekingalpha.com/news/3366144-dow-utilities-cap-best-eight-day-stretch-in-two-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3366144-dow-utilities-cap-best-eight-day-stretch-in-two-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366137\" data-ts=\"1529967814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTN\" target=\"_blank\">GTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366137-moodys-eyes-ratings-cut-for-gray-television-on-new-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moody&#39;s eyes ratings cut for Gray Television on new debt</a></h4><ul>   <li>Gray Television (NYSE:<a href='https://seekingalpha.com/symbol/GTN' title='Gray Television, Inc.'>GTN</a>) may face a ratings cut from Moody's after the company's transformative <a href=\"https://seekingalpha.com/news/3365956-gray-television-buying-raycom-media-3_6b\" target=\"_blank\">$3.6B deal</a> for Raycom Media.</li>    <li>Moody's expects ratings on Gray's term loans and unsecured notes will come under pressure in a pro forma capital structure heavier on secured debt, and leverage ratio will likely remain high for the rating category.</li>    <li>Gray <font color='green'>rose 16%</font> during the market session today to end up at its highest point since Feb. 12.</li>    <li>Source: Bloomberg</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3366137\" data-linked=\"Moody&#39;s eyes ratings cut for Gray Television on new debt\" data-tweet=\"$GTN - Moody&#39;s eyes ratings cut for Gray Television on new debt https://seekingalpha.com/news/3366137-moodys-eyes-ratings-cut-for-gray-television-on-new-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3366137-moodys-eyes-ratings-cut-for-gray-television-on-new-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366128\" data-ts=\"1529962620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366128-netflix-marks-worst-decline-in-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix marks worst decline in years</a></h4><ul>   <li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>), a relatively high-beta stock, took today's market decline particularly hard, <font color='red'>down 6.5%</font>.</li>    <li>That fall of $26.61 comes amid its worst intraday decline in nearly two years; it shaved some $11.5B off the company's market cap.</li>    <li>It's the third straight decline for the stock.</li>    <li>Late Friday, the company's chief communications officer said he was <a href=\"https://seekingalpha.com/news/3365895-netflix-comms-chief-exits-insensitive-comments-updated\" target=\"_blank\">departing the company</a> after incidents of insensitive comments came to light and were addressed by CEO Reed Hastings.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366128\" data-linked=\"Netflix marks worst decline in years\" data-tweet=\"$NFLX - Netflix marks worst decline in years https://seekingalpha.com/news/3366128-netflix-marks-worst-decline-in-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3366128-netflix-marks-worst-decline-in-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>98&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366127\" data-ts=\"1529962532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNGR\" target=\"_blank\">RNGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366127-after-hours-gainers-losers-06-25-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (06/25/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/RNGR' title='Ranger Energy Services'>RNGR</a>&nbsp;<font color='green'>+2.7%</font>. <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a>&nbsp;<font color='green'>+2.3%</font>. <a href='https://seekingalpha.com/symbol/TSG' title='The Stars Group Inc.'>TSG</a> <font color='green'>+1.6%</font>. <a href='https://seekingalpha.com/symbol/HUYA' title='Huya Broadcasting'>HUYA</a>&nbsp;<font color='green'>+1.6%</font>. <a href='https://seekingalpha.com/symbol/CVGI' title='Commercial Vehicle Group, Inc.'>CVGI</a> <font color='green'>+1.6%</font>.</li>     <li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/TVIX' title='VelocityShares Daily 2x VIX Short-Term ETN'>TVIX</a> <font color='red'>-4.1%</font>. <a href='https://seekingalpha.com/symbol/VIIX' title='VelocityShares VIX Short-Term ETN'>VIIX</a>&nbsp;<font color='red'>-1.9%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/HAIR' title='Restoration Robotics'>HAIR</a>&nbsp;<font color='red'>-1.8%.&nbsp;</font><a href='https://seekingalpha.com/symbol/CVNA' title='Carvana Co.'>CVNA</a>&nbsp;<font color='red'>-1.3%</font>. <a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a>&nbsp;<font color='red'>-1.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366127\" data-linked=\"After Hours Gainers / Losers (06/25/2018)\" data-tweet=\"$RNGR $RNGR $GWPH - After Hours Gainers / Losers (06/25/2018) https://seekingalpha.com/news/3366127-after-hours-gainers-losers-06-25-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366127-after-hours-gainers-losers-06-25-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366126\" data-ts=\"1529961921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRT\" target=\"_blank\">CPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366126-exelplus-5_4-on-move-to-midcap-400-cprt-to-s-and-p-500\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EXEL +5.4% on move to MidCap 400; CPRT to S&amp;P 500</a></h4><ul>   <li>Online auction provider Copart (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRT' title='Copart, Inc.'>CPRT</a>) is <font color='green'>up 0.5%</font> after hours as it's making a <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/731759_june25drpepperclarifications.pdf?force_download=true\" target=\"_blank\">move to the S&amp;P 500</a>, to take the place of Dr Pepper Snapple.</li>    <li>When Dr Pepper Snapple (NYSE:<a href='https://seekingalpha.com/symbol/DPS-OLD' title='Dr Pepper Snapple Group, Inc.'>DPS-OLD</a>) merges with Keurig Green Mountain to become Keurig Dr Pepper (NYSE:<a href='https://seekingalpha.com/symbol/KDP' title='Keurig Dr Pepper Inc'>KDP</a>), its Investable Weight Factor (measuring the percentage of free float available to the public) will fall below 50%, the minimum threshold required to be included in the S&amp;P 500.</li>    <li>Meanwhile, biotech firm Exelixis (NASDAQ:<a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a>) is <font color='green'>up 5.4%</font> in late trading, moving into the MidCap 400 to take the spot vacated by Copart.</li>    <li>Those moves are effective prior to the open of trading on Monday, July 2.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366126\" data-linked=\"EXEL +5.4% on move to MidCap 400; CPRT to S&amp;P 500\" data-tweet=\"$CPRT $CPRT $DPS-OLD - EXEL +5.4% on move to MidCap 400; CPRT to S&amp;P 500 https://seekingalpha.com/news/3366126-exelplus-5_4-on-move-to-midcap-400-cprt-to-s-and-p-500?source=tweet\" data-url=\"https://seekingalpha.com/news/3366126-exelplus-5_4-on-move-to-midcap-400-cprt-to-s-and-p-500\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366125\" data-ts=\"1529961321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SENS\" target=\"_blank\">SENS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366125-senseonicsminus-5_8-on-80m-public-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Senseonics -5.8% on $80M public share offering</a></h4><ul>   <li>Senseonics Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings'>SENS</a>) is <font color='red'>off 5.8%</font> after hours after announcing a <a href=\"https://seekingalpha.com/pr/17200977-senseonics-announces-public-offering-common-stock\" target=\"_blank\">public offering</a> of $80M worth of common stock.</li>    <li>The offering is set to come at $4.05/share, Bloomberg notes; shares had closed today at $4.66 and are quoting at $4.43 after hours.</li>    <li>Underwriters will get a 30-day option to buy up to an additional $12M worth.</li>    <li>Senseonics is selling all shares in the offering.</li>    <li>BTIG is sole book-runner.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3366125\" data-linked=\"Senseonics -5.8% on $80M public share offering\" data-tweet=\"$SENS - Senseonics -5.8% on $80M public share offering https://seekingalpha.com/news/3366125-senseonicsminus-5_8-on-80m-public-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3366125-senseonicsminus-5_8-on-80m-public-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366123\" data-ts=\"1529960955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBIO\" target=\"_blank\">CBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366123-catalyst-bioplus-3_1-point72-discloses-5_5-passive-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Bio +3.1% as Point72 discloses 5.5% passive stake</a></h4><ul>   <li>Catalyst Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a>) shareholder Point72 and Steven Cohen have reported a 5.5% stake in the company.</li>    <li>The <a href=\"https://seekingalpha.com/filing/4078239\" target=\"_blank\">13G filing</a> indicates a passively held stake of 651,000 shares -- a little over $7.06M worth at current pricing.</li>    <li>Shares have <font color='green'>ticked up 3.1%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366123\" data-linked=\"Catalyst Bio +3.1% as Point72 discloses 5.5% passive stake\" data-tweet=\"$CBIO - Catalyst Bio +3.1% as Point72 discloses 5.5% passive stake https://seekingalpha.com/news/3366123-catalyst-bioplus-3_1-point72-discloses-5_5-passive-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3366123-catalyst-bioplus-3_1-point72-discloses-5_5-passive-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366115\" data-ts=\"1529959569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNSS\" target=\"_blank\">SNSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366115-sunesisplus-1_9-on-15_5m-repurchase-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunesis +1.9% on $15.5M repurchase agreement</a></h4><ul><li>        Sunesis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNSS' title='Sunesis Pharmaceuticals, Inc.'>SNSS</a>) <a href=\"https://seekingalpha.com/pr/17200976-sunesis-pharmaceuticals-enters-15_5-million-common-stock-purchase-agreement-aspire-capital\" target=\"_blank\">enters</a> a repurchase program of up to $15.5M shares with Aspire Capital Fund.</li><li>                  Under the agreement, Aspire Capital has made an initial investment by purchasing $500K worth of common shares at $2.19/share.    </li><li>               Aspire Capital commits to purchasing up to an additional $15M of common shares at the request of Sunesis during a 24-month period.&nbsp;</li><li>               Sunesis Pharmaceuticals shares are&nbsp;<font color='green'>up 1.9%</font>&nbsp;aftermarket to $2.15.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366115\" data-linked=\"Sunesis +1.9% on $15.5M repurchase agreement\" data-tweet=\"$SNSS - Sunesis +1.9% on $15.5M repurchase agreement https://seekingalpha.com/news/3366115-sunesisplus-1_9-on-15_5m-repurchase-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3366115-sunesisplus-1_9-on-15_5m-repurchase-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366105\" data-ts=\"1529957465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIDM\" target=\"_blank\">CIDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366105-cinedigm-reports-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cinedigm reports Q4 results</a></h4><ul><li>Cinedigm (NASDAQ:<a href='https://seekingalpha.com/symbol/CIDM' title='Cinedigm Corp.'>CIDM</a>): Q4 net income of $0.046M</li><li>Revenue of $17.64M (-10.0% Y/Y)</li><li>Shares <font color='green'>+13.16%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17200968-cinedigm-announces-fourth-quarter-full-year-fiscal-2018-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3366105\" data-linked=\"Cinedigm reports Q4 results\" data-tweet=\"$CIDM - Cinedigm reports Q4 results https://seekingalpha.com/news/3366105-cinedigm-reports-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3366105-cinedigm-reports-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366103\" data-ts=\"1529957397\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRTX\" target=\"_blank\">HRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366103-heron-therapeuticsminus-2_7-on-200m-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heron Therapeutics -2.7% on $200M stock offering</a></h4><ul><li>        Heron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a>) <a href=\"https://seekingalpha.com/pr/17200942-heron-therapeutics-announces-public-offering-common-stock\" target=\"_blank\">announce</a>s a public offering of $200M of common stock. Initial purchasers get a 30-day option for up to $30M of additional shares.</li><li>               Heron Therapeutics shares are&nbsp;<font color='red'>down 2.7%</font>&nbsp;aftermarket to $40.35.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366103\" data-linked=\"Heron Therapeutics -2.7% on $200M stock offering\" data-tweet=\"$HRTX - Heron Therapeutics -2.7% on $200M stock offering https://seekingalpha.com/news/3366103-heron-therapeuticsminus-2_7-on-200m-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3366103-heron-therapeuticsminus-2_7-on-200m-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366101\" data-ts=\"1529956697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERYP\" target=\"_blank\">ERYP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366101-erytech-pharmaminus-29-after-stopping-development-of-key-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Erytech Pharma -29% after stopping development of key drug</a></h4><ul>     <li>Erytech Pharma (<a href='https://seekingalpha.com/symbol/ERYP' title='Erytech Pharma S.A. ADS'>ERYP</a> <font color='red'>-29.2%</font>) plunges to a record low after saying it will <a href=\"https://seekingalpha.com/pr/17199846-erytech-confirms-strategic-focus-eryaspase-solid-tumors-ceases-development-acute\" target=\"_blank\">stop its development program</a> for its eryaspase product candidate in acute lymphoblastic leukemia.</li>     <li>Citing feedback from regulatory agencies in Europe and the U.S., ERYP says significant additional investment would be required in order to seek approval of eryaspase for the treatment of ALL.</li><li>The company says it will instead focus its development efforts for eryaspase on the potential treatment of selected solid tumor  indications.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3366101\" data-linked=\"Erytech Pharma -29% after stopping development of key drug\" data-tweet=\"$ERYP $EYRYY - Erytech Pharma -29% after stopping development of key drug https://seekingalpha.com/news/3366101-erytech-pharmaminus-29-after-stopping-development-of-key-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/3366101-erytech-pharmaminus-29-after-stopping-development-of-key-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366098\" data-ts=\"1529955936\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUBI\" target=\"_blank\">RUBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366098-rubicon-criteo-drop-after-and-t-confirms-purchase-of-ad-platform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rubicon, Criteo drop after AT&amp;T confirms purchase of ad platform</a></h4><ul><li>        The Rubicon Project (NYSE:<a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a>)&nbsp;<font color='red'>drops 9.6%</font>&nbsp;to $2.27 and Criteo (NASDAQ:<a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a>)&nbsp;<font color='red'>drops 1.1%</font>&nbsp;to $33.48 after AT&amp;T confirms its acquisition of ad platform AppNexus.&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365978-t-seals-deal-appnexus\" target=\"_blank\">AT&amp;T seals deal for AppNexus</a> (June 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366098\" data-linked=\"Rubicon, Criteo drop after AT&amp;T confirms purchase of ad platform\" data-tweet=\"$RUBI $RUBI $CRTO - Rubicon, Criteo drop after AT&amp;T confirms purchase of ad platform https://seekingalpha.com/news/3366098-rubicon-criteo-drop-after-and-t-confirms-purchase-of-ad-platform?source=tweet\" data-url=\"https://seekingalpha.com/news/3366098-rubicon-criteo-drop-after-and-t-confirms-purchase-of-ad-platform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366097\" data-ts=\"1529955597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HZO\" target=\"_blank\">HZO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366097-marinemaxminus-14-brunswicks-sea-ray-restructure-adds-uncertainty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MarineMax -14% as Brunswick&#39;s Sea Ray restructure adds uncertainty</a></h4><ul>     <li>MarineMax (<a href='https://seekingalpha.com/symbol/HZO' title='MarineMax Inc.'>HZO</a> <font color='red'>-14%</font>) plunges following Brunswick's (<a href='https://seekingalpha.com/symbol/BC' title='Brunswick Corporation'>BC</a> <font color='red'>-3.3%</font>) <a href=\"https://seekingalpha.com/news/3365989-brunswick-ends-sea-ray-sale-process-plans-restructure-business\" target=\"_blank\">failure to  sell its Sea Ray division</a> and decision to discontinue Sea Ray's yacht and sport yacht business, which prompts Craig Hallum to <a href=\"https://thefly.com/thestreet/realmoney/index.php/HZO%3bBCid2750109/HZO%3bBC-MarineMax-downgraded-to-Hold-on-risk-from-Sea-Ray-shift-at-CraigHallum\" target=\"_blank\">downgrade</a> HZO to Hold from Buy with a $22 price target, cut from $27, saying news adds \"risk and uncertainty\" for the company.</li>     <li>HZO is the world's largest retailer of Sea Ray boats, historically representing more than 50% of Sea Ray&rsquo;s worldwide sales, and the Sea Ray brand accounted for 23% of its FY 2017 revenue, but CEO&nbsp;William McGill says the company's brand and product diversification will allow it to <a href=\"https://seekingalpha.com/pr/17200655-marinemax-provides-update-sea-ray\" target=\"_blank\">replace the Sea Ray sport yacht and yacht revenue</a>.</li>     <li>Given the \"crucial importance\" of Sea Ray to HZO's business, Craig-Hallum says it is prudent to step to the sidelines pending better visibility on BC's intention.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366097\" data-linked=\"MarineMax -14% as Brunswick&#39;s Sea Ray restructure adds uncertainty\" data-tweet=\"$HZO $HZO $BC - MarineMax -14% as Brunswick&#39;s Sea Ray restructure adds uncertainty https://seekingalpha.com/news/3366097-marinemaxminus-14-brunswicks-sea-ray-restructure-adds-uncertainty?source=tweet\" data-url=\"https://seekingalpha.com/news/3366097-marinemaxminus-14-brunswicks-sea-ray-restructure-adds-uncertainty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366093\" data-ts=\"1529954277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366093-polarityte-gets-support-from-cantor-fitzgerald-shares-stillminus-28\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PolarityTE gets support from Cantor Fitzgerald; shares still -28%</a></h4><ul>     <li>PolarityTE (COOL <font color='red'>-28.6%</font>) is reiterated with an <a href=\"https://thefly.com/thestreet/realmoney/index.php/COOLid2750115/COOL-Cantor-reiterates-Overweight-rating-on-PolarityTE-after-meeting-with-doctors\" target=\"_blank\">Overweight rating</a> and $65 price target at Cantor Fitzgerald after attending a company-sponsored event and hearing three surgeons describe their clinical experiences using SkinTE and views on the transformative potential of the wound regeneration product.</li>     <li>The firm thinks COOL is positioned long-term  to \"redefine the treatment landscape for wound regeneration,\" and says today's stock plunge may be caused by the market's misunderstanding of the company's IP strategy and interaction with the U.S. Patent and Trademark Office.</li>     <li>Cantor's note does not mention Citron Research, which today <a href=\"https://seekingalpha.com/news/3366057-polarityte-minus-28-percent-citron-accuses-fraud\" target=\"_blank\">accused COOL of fraud</a> in its promotion of patents to  investors.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366093\" data-linked=\"PolarityTE gets support from Cantor Fitzgerald; shares still -28%\" data-tweet=\"$PTE - PolarityTE gets support from Cantor Fitzgerald; shares still -28% https://seekingalpha.com/news/3366093-polarityte-gets-support-from-cantor-fitzgerald-shares-stillminus-28?source=tweet\" data-url=\"https://seekingalpha.com/news/3366093-polarityte-gets-support-from-cantor-fitzgerald-shares-stillminus-28\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366091\" data-ts=\"1529953483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOXL\" target=\"_blank\">BOXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366091-boxlight-completes-acquisition-of-qwizdom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boxlight completes the acquisition of Qwizdom</a></h4><ul>     <li>Boxlight (<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a> <font color='red'>-5%</font>) <a href=\"https://seekingalpha.com/pr/17200298-boxlight-announces-acquisition-qwizdom\" target=\"_blank\">acquired</a> Qwizdom for cash, debt and common stock valued at ~$2.5M.</li>     <li>Qwizdom develops software and hardware solutions that are quick to implement and designed to increase participation, provide immediate data feedback, and, most importantly, accelerate and improve comprehension and learning.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3366091\" data-linked=\"Boxlight completes the acquisition of Qwizdom\" data-tweet=\"$BOXL - Boxlight completes the acquisition of Qwizdom https://seekingalpha.com/news/3366091-boxlight-completes-acquisition-of-qwizdom?source=tweet\" data-url=\"https://seekingalpha.com/news/3366091-boxlight-completes-acquisition-of-qwizdom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366087\" data-ts=\"1529953239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366087-rbc-analyst-says-amazon-double-whole-foods-business-in-5-to-10-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC analyst says Amazon could double Whole Foods business in 5 to 10 years</a></h4><ul><li>        RBC analyst Mark Mahaney <a href=\"https://www.cnbc.com/2018/06/25/mark-mahaney-amazon-could-double-whole-foods-customer-base-with-prime.html\" target=\"_blank\">says</a> Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) could double Whole Food&rsquo;s customer base.</li><li>               During an appearance on CNBC, Mahaney said that if Amazon had 60M to 70M U.S. Prime customers, about 20M to 30M live near a Whole Foods but &ldquo;don&rsquo;t regularly shop there.&rdquo;&nbsp;</li><li>               Mahaney continues that Amazon &ldquo;could double, theoretically, Whole Foods overall customer base over a 5 to 10 year period just by giving financial incentives to Prime customers.&rdquo;&nbsp;</li><li>               Mahaney has an Outperform rating on Amazon with a $1,900 price target, a 10% upside to Friday&rsquo;s close. &nbsp;&nbsp;</li><li>               Amazon shares are&nbsp;<font color='red'>down 3.7%</font>&nbsp;to $1,651.74.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366018-amazon-roundup-whole-foods-discounts-nationwide-fired-workers-can-now-appeal\" target=\"_blank\">Amazon roundup: Whole Foods discounts nationwide, fired workers can now appeal</a> (June 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366087\" data-linked=\"RBC analyst says Amazon could double Whole Foods business in 5 to 10 years\" data-tweet=\"$AMZN - RBC analyst says Amazon could double Whole Foods business in 5 to 10 years https://seekingalpha.com/news/3366087-rbc-analyst-says-amazon-double-whole-foods-business-in-5-to-10-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3366087-rbc-analyst-says-amazon-double-whole-foods-business-in-5-to-10-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366089\" data-ts=\"1529953176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366089-copper-hits-nearly-three-month-low-on-u-s-china-trade-tension\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Copper hits nearly three-month low on U.S.-China trade tension</a></h4><ul>     <li>Copper prices tumbled to their <a href=\"https://www.wsj.com/articles/copper-hits-june-low-amid-u-s-china-tension-1529944637\" target=\"_blank\">lowest close in nearly three months</a>, settling <font color='red'>-1.3%</font> at $2.992/lb. to cap a ~10% drop from a peak earlier this month.</li>     <li>There is &ldquo;concern globally about what trade wars mean for metals,&rdquo; says Nitesh Shah, director of research at WisdomTree. &ldquo;Over the last couple of weeks or so, people have been thinking of the impact as a very negative thing for industrial metals.&rdquo;</li>     <li>Traders are betting that the likelihood of a negotiated solution that avoids tariffs has become more distant, potentially hurting global growth and damping demand for industrial metals such as copper: China consumes ~50% of the world&rsquo;s copper.</li>     <li>Copper traders also are watching labor negotiations at two copper mines controlled by Chile's Codelco - including the Chuquicamata mine, home to one of the world&rsquo;s largest copper deposits - that potentially could reduce supply.</li><li>Major global metals producers are sharply lower: <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='red'>-5.4%</font>, <a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='red'>-3%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='red'>-2.8%</font>, <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='red'>-2.7%</font>, <a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color='red'>-6.3%</font>, <a href='https://seekingalpha.com/symbol/SCCO' title='Southern Copper Corporation'>SCCO</a> <font color='red'>-1.6%</font>, <a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='red'>-4.1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/JJC' title='iPath Series B Bloomberg Copper Subindex Total Return ETN'>JJC</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Copper Index ETF'>CPER</a>, <a href='https://seekingalpha.com/symbol/CUPM' title='iPath Pure Beta Copper ETN'>CUPM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3366089\" data-linked=\"Copper hits nearly three-month low on U.S.-China trade tension\" data-tweet=\"$FCX $FCX $BHP - Copper hits nearly three-month low on U.S.-China trade tension https://seekingalpha.com/news/3366089-copper-hits-nearly-three-month-low-on-u-s-china-trade-tension?source=tweet\" data-url=\"https://seekingalpha.com/news/3366089-copper-hits-nearly-three-month-low-on-u-s-china-trade-tension\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366086\" data-ts=\"1529952973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABIL\" target=\"_blank\">ABIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366086-technology-top-5-gainers-losers-of-2_55-pm-06-25-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (06/25/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+84%</font>. <a href='https://seekingalpha.com/symbol/TSRI' title='TSR, Inc.'>TSRI</a> <font color='green'>+39%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck Mobilisa, Inc.'>IDN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CBAK-OLD' title='China BAK Battery, Inc.'>CBAK-OLD</a> <font color='green'>+7%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/RMNI' title='Rimini Street'>RMNI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/WUBA' title='58.com Inc.'>WUBA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a> <font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3366086\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (06/25/2018)\" data-tweet=\"$ABIL $ABIL $TSRI - Technology - Top 5 Gainers / Losers as of 2.55 PM (06/25/2018) https://seekingalpha.com/news/3366086-technology-top-5-gainers-losers-of-2_55-pm-06-25-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366086-technology-top-5-gainers-losers-of-2_55-pm-06-25-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366081\" data-ts=\"1529950387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366081-sprints-claure-t-mobiles-legere-heading-to-congress\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint&#39;s Claure, T-Mobile&#39;s Legere heading to Congress</a></h4><ul>   <li>Top leaders of the nation's No. 3 and No. 4 wireless carriers will appear on Capitol Hill this week to speak on the merits of their proposed merger.</li>    <li>Sprint's (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color='red'>-2.9%</font>) Marcelo Claure and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color='red'>-2%</font>) chief John Legere will appear at a <a href=\"https://www.judiciary.senate.gov/meetings/game-of-phones-examining-the-competitive-impact-of-the-t-mobile_sprint-transaction\" target=\"_blank\">Wednesday \"Game of Phones\" hearing</a> of the Senate Judiciary's Subcommittee on Antitrust, Competition Policy, and Consumer Rights, the panel says.</li>    <li>Intel tech VP Asha Keddy is also set to appear, the panel says.</li>    <li>T-Mobile officially <a href=\"https://seekingalpha.com/news/3364950-t-mobile-sprint-formally-file-fcc-merger\" target=\"_blank\">filed its Public Interest Statement</a> with the FCC in favor of its $26.5B merger deal last week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366081\" data-linked=\"Sprint&#39;s Claure, T-Mobile&#39;s Legere heading to Congress\" data-tweet=\"$S $S $TMUS - Sprint&#39;s Claure, T-Mobile&#39;s Legere heading to Congress https://seekingalpha.com/news/3366081-sprints-claure-t-mobiles-legere-heading-to-congress?source=tweet\" data-url=\"https://seekingalpha.com/news/3366081-sprints-claure-t-mobiles-legere-heading-to-congress\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366077\" data-ts=\"1529949653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGCYO\" target=\"_blank\">LGCYO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366077-energy-materials-top-5-gainers-losers-of-2-00-pm-06-25-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/25/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LGCYO' title='Legacy Reserves LP Cum Red Perp Pfd Units Series B'>LGCYO</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/LGCYP' title='Legacy Reserves LP Cum Red Perp Pfd Units Series A'>LGCYP</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/PEIX' title='Pacific Ethanol, Inc.'>PEIX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AMID' title='American Midstream Partners, LP'>AMID</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CELP' title='Cypress Energy Partners, L.P.'>CELP</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MBII' title='Marrone Bio Innovations, Inc.'>MBII</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CSTM' title='Constellium Holdco B.V.'>CSTM</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366077\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/25/2018)\" data-tweet=\"$LGCYO $LGCYO $LGCYP - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/25/2018) https://seekingalpha.com/news/3366077-energy-materials-top-5-gainers-losers-of-2-00-pm-06-25-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366077-energy-materials-top-5-gainers-losers-of-2-00-pm-06-25-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366078\" data-ts=\"1529949539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366078-boeingminus-2-despite-5_6b-dreamliner-order-barclays-still-believer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing -2% despite $5.6B Dreamliner order; Barclays still a believer</a></h4><ul>     <li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='red'>-2.3%</font>) is the day's <a href=\"https://www.marketwatch.com/story/boeing-wins-dreamliner-orders-valued-at-56-billion-but-stock-still-the-biggest-drag-on-the-dow-2018-06-25\" target=\"_blank\">biggest decliner on the Dow</a> despite winning a commitment from Vietnamese startup air carrier Bamboo Airways to <a href=\"https://seekingalpha.com/pr/17200782-boeing-bamboo-airways-announce-commitment-20-787-dreamliners\" target=\"_blank\">buy 20 787-9 Dreamliners</a> in a deal that could worth $5.6B at list prices.</li>     <li>BA says Bamboo completed the deposit requirement to reserve the 20 planes, which are tentatively scheduled to deliver from April 2020 through 2021.</li>     <li>Barclays analyst David Strauss overlooks the tariff worries that have weighed on BA shares, <a href=\"https://www.barrons.com/articles/boeings-free-cash-flow-is-first-class-1529947669?mod=hp_RTA\" target=\"_blank\">reiterating an Overweight rating</a> and $400 price target, saying the company is still in the \"early days of benefiting from a heightened focus on cost reduction and improved productivity\" that will boost margins and free cash flow.</li>     <li>Strauss forecasts Boeing will record more than $30/share in free cash flow in 2020, including $5B in free cash flow&nbsp;from prepayments in 2018, more than double the $2B YTD and above last year's $4.5B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366078\" data-linked=\"Boeing -2% despite $5.6B Dreamliner order; Barclays still a believer\" data-tweet=\"$BA - Boeing -2% despite $5.6B Dreamliner order; Barclays still a believer https://seekingalpha.com/news/3366078-boeingminus-2-despite-5_6b-dreamliner-order-barclays-still-believer?source=tweet\" data-url=\"https://seekingalpha.com/news/3366078-boeingminus-2-despite-5_6b-dreamliner-order-barclays-still-believer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366075\" data-ts=\"1529947868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366075-cbs-extends-nfl-streaming-deal-through-2022-adds-mobile-access\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBS extends NFL streaming deal through 2022, adds mobile access</a></h4><ul>   <li>CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='red'>-1.8%</font>) has <a href=\"https://seekingalpha.com/pr/17200792-cbs-extends-agreement-stream-nfl-games-cbs-access-2022-expands-streaming-rights-mobile\" target=\"_blank\">extended its streaming deal with the NFL</a>, allowing for all NFL on CBS games to be streamed on CBS All Access through the 2022 season.</li>    <li>It's also extended rights to include mobile devices beginning this season, for CBS All Access subscribers and TV Everywhere viewers who are authenticated by their pay TV providers.</li>    <li>CBS started streaming NFL on CBS games to its All Access subs in 2016 for connected TVs, tablets and computers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366075\" data-linked=\"CBS extends NFL streaming deal through 2022, adds mobile access\" data-tweet=\"$CBS $VIAC - CBS extends NFL streaming deal through 2022, adds mobile access https://seekingalpha.com/news/3366075-cbs-extends-nfl-streaming-deal-through-2022-adds-mobile-access?source=tweet\" data-url=\"https://seekingalpha.com/news/3366075-cbs-extends-nfl-streaming-deal-through-2022-adds-mobile-access\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366074\" data-ts=\"1529947364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366074-semiconductor-stocks-drop-on-reported-investment-restrictions-on-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semiconductor stocks drop on reported investment restrictions on China</a></h4><ul><li>        Semiconductor stocks are taking a beating today after early morning reports and U.S. Treasury Secretary Steven Mnuchin&rsquo;s <a href=\"https://twitter.com/stevenmnuchin1/status/1011258207182966786?ref_src=twsrc%5Etfw&amp;ref_url=https%3A%2F%2Fwww.cnbc.com%2F2018%2F06%2F25%2Ftreasury-secretary-mnuchin-says-investment-restrictions-will-apply-to-.html\" target=\"_blank\">response tweet</a> about reported investment restrictions on China.</li><li>               Mnuchin&rsquo;s tweet: \"On behalf of @realDonaldTrump, the stories on investment restrictions in Bloomberg &amp; WSJ are false, fake news. The leaker either doesn&rsquo;t exist or know the subject very well. Statement will be out not specific to China, but to all countries that are trying to steal our technology.\"&nbsp;&nbsp;</li><li>               The Philadelphia Semiconductor Index is&nbsp;<font color='red'>down 3.7%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>           Semiconductors stocks on the move: Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='red'>-7%</font>), Nvidia (<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='red'>-5.7%</font>), Marvell (<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a> <font color='red'>-5.6%</font>), AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-5.5%</font>), ON Semiconductors (<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a> <font color='red'>-5.2%</font>), ASML (<a href='https://seekingalpha.com/symbol/ASML' title='ASML Holding N.V.'>ASML</a> <font color='red'>-5%</font>), Cypress Semiconductors (<a href='https://seekingalpha.com/symbol/CY' title='Cypress Semiconductor Corporation'>CY</a> <font color='red'>-4.9%</font>), Monolith Power (<a href='https://seekingalpha.com/symbol/MPWR' title='Monolithic Power Systems, Inc.'>MPWR</a> <font color='red'>-4.2%</font>), Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>-4.2%</font>), MKS Instruments (<a href='https://seekingalpha.com/symbol/MKSI' title='MKS Instruments, Inc.'>MKSI</a> <font color='red'>-4.1%</font>), Cree (<a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a> <font color='red'>-3.8%</font>), Cavium (CAVM <font color='red'>-3.8%</font>), Teradyne (<a href='https://seekingalpha.com/symbol/TER' title='Teradyne Inc.'>TER</a> <font color='red'>-3.6%</font>), Applied Materials (<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color='red'>-3.7%</font>), Silicon Motion (<a href='https://seekingalpha.com/symbol/SIMO' title='Silicon Motion Technology Corporation'>SIMO</a> <font color='red'>-3.5%</font>), Microchip (<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a> <font color='red'>-3.7%</font>), Maxim (<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a> <font color='red'>-3.6%</font>), Integrated Device (<a href='https://seekingalpha.com/symbol/IDTI' title='Integrated Device Technology, Inc.'>IDTI</a> <font color='red'>-3.5%</font>), Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='red'>-3.1%</font>), Texas Instruments (<a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Inc.'>TXN</a> <font color='red'>-3%</font>), Qualcomm (<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a> <font color='red'>-2.9%</font>), Xilinx (<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a> <font color='red'>-2.7%</font>), Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='red'>-2.5%</font>), Analog Devices (<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a> <font color='red'>-2%</font>), and InterDigital (<a href='https://seekingalpha.com/symbol/IDCC' title='InterDigital, Inc.'>IDCC</a> <font color='red'>-2.1%</font>).&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3365979-nomura-downgrades-intel-ceo-search-intc-minus-2_3-percent\" target=\"_blank\">Nomura downgrades Intel on CEO search; INTC -2.3%</a> (June 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365927-futures-fall-trump-targets-chinese-investment\" target=\"_blank\">Futures fall as Trump targets Chinese investment</a> (June 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366043-nasdaq-tumbles-2-percent-mnuchin-clarifies-china-tech-crackdown\" target=\"_blank\">Nasdaq tumbles 2%; Mnuchin clarifies on China tech crackdown</a> (June 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366074\" data-linked=\"Semiconductor stocks drop on reported investment restrictions on China\" data-tweet=\"$MU $MU $NVDA - Semiconductor stocks drop on reported investment restrictions on China https://seekingalpha.com/news/3366074-semiconductor-stocks-drop-on-reported-investment-restrictions-on-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3366074-semiconductor-stocks-drop-on-reported-investment-restrictions-on-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>229&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366073\" data-ts=\"1529947346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFT\" target=\"_blank\">WFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366073-weatherford-targeted-activist-investor-says-ceo-woefully-inadequate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weatherford targeted by activist investor, says CEO &#39;woefully inadequate&#39;</a></h4><ul>     <li>Weatherford International (<a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a> <font color='red'>-3.2%</font>) is being targeted by activist investor Q Investments, which has taken a small stake in the company and <a href=\"https://www.ft.com/content/40cbcc9c-74d6-11e8-b6ad-3823e4384287\" target=\"_blank\">urges the board to sell assets or the entire company</a> before its &ldquo;over-levered capital structure&rdquo; destroy &ldquo;what remaining value the shareholders have left,\"&nbsp;<em>Financial Times</em> reports.</li>     <li>Q's stake in WFT is just 0.02% but the fund believes other investors also are unhappy about the company&rsquo;s performance and will join its campaign for change; shares have slipped 16% over the past 12 months, while peers Halliburton and Schlumberger have gained 10% and 2%, respectively.</li>     <li>Q says &ldquo;the current dilapidated financial condition of the company&rdquo; masks WFT's &ldquo;underlying strong portfolio of businesses and technologies,\" and that efforts by CEO&nbsp;Mark McCollum to reverse the company&rsquo;s performance are &ldquo;woefully inadequate.\"</li>     <li>The fund is not yet calling for new board members but says it is &ldquo;incomprehensible&rdquo; that six directors who were in place during the tenure of previous CEO Bernard Duroc-Danner are still on the board.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366073\" data-linked=\"Weatherford targeted by activist investor, says CEO &#39;woefully inadequate&#39;\" data-tweet=\"$WFT $WFTIQ - Weatherford targeted by activist investor, says CEO &#39;woefully inadequate&#39; https://seekingalpha.com/news/3366073-weatherford-targeted-activist-investor-says-ceo-woefully-inadequate?source=tweet\" data-url=\"https://seekingalpha.com/news/3366073-weatherford-targeted-activist-investor-says-ceo-woefully-inadequate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366072\" data-ts=\"1529946733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XENE\" target=\"_blank\">XENE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366072-xenon-pharmaplus-3_9-potiga-gets-orphan-drug-status\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xenon Pharma +3.9% as Potiga gets orphan drug status</a></h4><ul>   <li>Xenon Pharmaceuticals (<a href=\"http://seekingalpha.com/symbol/XENE\" target=\"_blank\">XENE</a> <font color='green'>+3.9%</font>) has won <a href=\"https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=639118\" target=\"_blank\">orphan drug status</a> for its Potiga (ezogabine) in the treatment of KCNQ2 epileptic encephalopathy.</li>    <li>That designation came on Thursday.</li>    <li>It could mean seven years' exclusivity if approved for a rare disease.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366072\" data-linked=\"Xenon Pharma +3.9% as Potiga gets orphan drug status\" data-tweet=\"$XENE - Xenon Pharma +3.9% as Potiga gets orphan drug status https://seekingalpha.com/news/3366072-xenon-pharmaplus-3_9-potiga-gets-orphan-drug-status?source=tweet\" data-url=\"https://seekingalpha.com/news/3366072-xenon-pharmaplus-3_9-potiga-gets-orphan-drug-status\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366070\" data-ts=\"1529946429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGX\" target=\"_blank\">DGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366070-quest-diagnostics-moves-up-barclays-upgrades-to-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quest Diagnostics moves up as Barclays upgrades to Overweight</a></h4><ul>     <li>Quest Diagnostics (<a href='https://seekingalpha.com/symbol/DGX' title='Quest Diagnostics Incorporated'>DGX</a> <font color='green'>+2.5%</font>) is higher after Barclays <a href=\"https://www.streetinsider.com/Analyst+Comments/Barclays+Upgrades+Quest+Diagnostics+%28DGX%29+to+Overweight/14337149.html\" target=\"_blank\">upgrades shares to Overweight</a> from Equal Weight and raises its price target to $130 from $120, saying the new payor paradigm accelerates opportunities for lab consolidation and new data service opportunities.</li><li>Barclays believes it could be a big deal that UnitedHealth (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a> <font color='red'>-1.1%</font>) will share savings with preferred labs as volume shifts from high-cost settings, a first for the lab industry.</li><li>The firm says its primary care  physician survey shows both Quest and LabCorp (<a href='https://seekingalpha.com/symbol/LH' title='Laboratory Corporation of America Holdings'>LH</a> <font color='red'>-0.3%</font>) should gain share as payor networks open.</li><li>Barclays also says potential changes in benefit design could include new incentives for both physicians and patients to  drive volumes toward preferred labs, which would align all parties to drive value for the healthcare system.</li><li>Finally, the firm thinks the pieces are in place for Quest to more meaningfully leverage its diagnostic data asset with customers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366070\" data-linked=\"Quest Diagnostics moves up as Barclays upgrades to Overweight\" data-tweet=\"$DGX $DGX $UNH - Quest Diagnostics moves up as Barclays upgrades to Overweight https://seekingalpha.com/news/3366070-quest-diagnostics-moves-up-barclays-upgrades-to-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3366070-quest-diagnostics-moves-up-barclays-upgrades-to-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366069\" data-ts=\"1529946389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYBX\" target=\"_blank\">SYBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366069-synlogic-offers-new-synthetic-biologic-preclinical-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synlogic offers new Synthetic Biologic preclinical data</a></h4><ul>   <li>Synlogic (<a href=\"http://seekingalpha.com/symbol/SYBX\" target=\"_blank\">SYBX</a> <font color='red'>-8.2%</font>) has offered up <a href=\"https://seekingalpha.com/pr/17200087-synlogic-presents-new-preclinical-data-synthetic-biotic-immuno-oncology-program-focis-2018\" target=\"_blank\">new preclinical data</a> from its Synthetic Biotic oncology program.</li>    <li>The data show that intra-tumorally injected E. coli Nissle -- used as the parent strain for Synthetic Biotic medicines -- has the ability to colonize and persist in tumors, and that multiple functions can be engineered into a single bacterial strain.</li>    <li>That points to using the Syntheic Biotic approach to potentially treat solid tumors, including \"cold\" tumors resitant to current immunotherapies.</li>    <li>The data also demonstrate using \"switches\" to direct functions in the medicines in response to environmental cues or exogenously administered small molecules.</li>    <li>A second presentation covered mouse tumor model studies where one engineered strain lowered levels of kynurenine metabolite by degrading it.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366069\" data-linked=\"Synlogic offers new Synthetic Biologic preclinical data\" data-tweet=\"$SYBX - Synlogic offers new Synthetic Biologic preclinical data https://seekingalpha.com/news/3366069-synlogic-offers-new-synthetic-biologic-preclinical-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3366069-synlogic-offers-new-synthetic-biologic-preclinical-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366068\" data-ts=\"1529946149\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366068-fda-approves-first-cannabis-based-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA approves first cannabis-based drug</a></h4><ul><li>        The <a href=\"https://endpts.com/breaking-fda-oks-first-cannabinoid-gives-green-light-to-gw-pharmas-epidiolex-for-rare-seizures/\" target=\"_blank\">FDA approves</a> GW Pharma&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a>) Epidiolex to treat rare childhood seizures.</li><li>               Epidiolex is the first US-approved cannabinoid and the drug could achieve $1.2B in sales by 2022, according to Clarivate data.&nbsp;</li><li>               The potential approval was previously reported by the FT.&nbsp;</li><li>               GW Pharma shares are<font color='red'> down 1.2%</font>&nbsp;to $149.38.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365931-first-u-s-approval-cannabis-based-drug\" target=\"_blank\">First U.S. approval of cannabis-based drug</a> (June 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366068\" data-linked=\"FDA approves first cannabis-based drug\" data-tweet=\"$GWPH - FDA approves first cannabis-based drug https://seekingalpha.com/news/3366068-fda-approves-first-cannabis-based-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/3366068-fda-approves-first-cannabis-based-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366066\" data-ts=\"1529946052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HX\" target=\"_blank\">HX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366066-financials-top-gainers-losers-of-1-00-pm-06-25-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (06/25/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SAR' title='Saratoga Investment Corp'>SAR</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/YRD' title='Yirendai LTD.'>YRD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/FUNC' title='First United Corporation'>FUNC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance'>XRF</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366066\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (06/25/2018)\" data-tweet=\"$HX $HX $HGSH - Financials - Top Gainers / Losers as of 1:00 PM (06/25/2018) https://seekingalpha.com/news/3366066-financials-top-gainers-losers-of-1-00-pm-06-25-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366066-financials-top-gainers-losers-of-1-00-pm-06-25-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366061\" data-ts=\"1529944909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRM\" target=\"_blank\">XRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366061-midday-gainers-losers-06-25-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (06/25/2018)</a></h4><ul>     <li><strong>Gainers</strong>: <a href='https://seekingalpha.com/symbol/XRM' title='Xerium Technologies, Inc.'>XRM</a> <font color='green'>+100%</font>. <a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='green'>+96%</font>. <a href='https://seekingalpha.com/symbol/YECO-OLD' title='Yulong Eco-Materials'>YECO-OLD</a> <font color='green'>+69%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+66%</font>. <a href='https://seekingalpha.com/symbol/TSRI' title='TSR, Inc.'>TSRI</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/LGCYO' title='Legacy Reserves LP Cum Red Perp Pfd Units Series B'>LGCYO</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/ATV' title='Acorn International, Inc.'>ATV</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/CADC' title='China Advanced Construction Materials Group, Inc.'>CADC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/LGCYP' title='Legacy Reserves LP Cum Red Perp Pfd Units Series A'>LGCYP</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a> <font color='green'>+17%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/SPHS' title='Sophiris Bio'>SPHS</a> <font color='red'>-41%</font>. <a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a> <font color='red'>-39%</font>. COOL <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/LIVX' title='LiveXLive Media, Inc.'>LIVX</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SLNO' title='Soleno Therapeutics, Inc.'>SLNO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CDNA' title='CareDx'>CDNA</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CFRX' title='ContraFect Corp.'>CFRX</a> <font color='red'>-13%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3366061\" data-linked=\"Midday Gainers / Losers (06/25/2018)\" data-tweet=\"$XRM $XRM $XBIO - Midday Gainers / Losers (06/25/2018) https://seekingalpha.com/news/3366061-midday-gainers-losers-06-25-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366061-midday-gainers-losers-06-25-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366057\" data-ts=\"1529943211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366057-polarityteminus-28-after-citron-accuses-fraud\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PolarityTE -28% after Citron accuses fraud</a></h4><ul>     <li>PolarityTE (COOL <font color='red'>-28.4%</font>) plunges after Citron Research <a href=\"https://citronresearch.com/wp-content/uploads/2018/06/Citron-Exposes-History-of-FRAUD-Behind-PolarityTE.pdf\" target=\"_blank\">accuses the company of fraud</a> in raising money based on a patent application that was rejected earlier this month, and says the SEC should launch an investigation.</li>     <li>The SEC should halt trading in COOL shares \"immediately before insiders are allowed to enrich themselves even more as the company continues to deceive  investors,\" Citron says.</li>     <li>\"A group of serial stock promoters\" have profited without properly disclosing their receipt of a notice of non-final rejection of the company's  critical patent, according to Citron.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366057\" data-linked=\"PolarityTE -28% after Citron accuses fraud\" data-tweet=\"$PTE - PolarityTE -28% after Citron accuses fraud https://seekingalpha.com/news/3366057-polarityteminus-28-after-citron-accuses-fraud?source=tweet\" data-url=\"https://seekingalpha.com/news/3366057-polarityteminus-28-after-citron-accuses-fraud\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366056\" data-ts=\"1529943026\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLDB\" target=\"_blank\">SLDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366056-sarepta-dmd-treatment-gets-orphan-drug-designation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta DMD treatment gets orphan drug designation</a></h4><ul>   <li>Sarepta (<a href=\"http://seekingalpha.com/symbol/SRPT\" target=\"_blank\">SRPT</a> <font color='red'>-4%</font>) confirms its gene therapy treatment for Duchenne muscular dystrophy has gotten orphan drug designation at the FDA.</li>    <li>That gets it years of market exclusivity if approved.</li>    <li>Shares had <a href=\"https://seekingalpha.com/news/3364973-sarepta-plus-37_5-percent-sell-side-chimes\" target=\"_blank\">jumped a week ago</a> based on preliminary data from the treatment candidate.</li>    <li>Solid Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a>) is <font color='green'>up 6.7%</font> currently after seeing <a href=\"https://seekingalpha.com/news/3366048-solid-biosciences-plus-7_6-percent-amid-analyst-praise-dmd-approach\" target=\"_blank\">analyst praise today</a> for its DMD therapy.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366056\" data-linked=\"Sarepta DMD treatment gets orphan drug designation\" data-tweet=\"$SLDB $SLDB $SRPT - Sarepta DMD treatment gets orphan drug designation https://seekingalpha.com/news/3366056-sarepta-dmd-treatment-gets-orphan-drug-designation?source=tweet\" data-url=\"https://seekingalpha.com/news/3366056-sarepta-dmd-treatment-gets-orphan-drug-designation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366053\" data-ts=\"1529942452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMT\" target=\"_blank\">CMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366053-consumer-top-5-gainers-losers-of-12-00-pm-06-25-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/25/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CMT' title='Core Molding Technologies, Inc.'>CMT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CPB' title='Campbell Soup Company'>CPB</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/DLA' title='Delta Apparel, Inc'>DLA</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/EAST' title='Eastside Distilling, Inc.'>EAST</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CXDC' title='China XD Plastics Company Limited'>CXDC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FORK' title='Fuling Global'>FORK</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366053\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/25/2018)\" data-tweet=\"$CMT $CMT $CPB - Consumer - Top 5 Gainers / Losers as of 12:00 PM (06/25/2018) https://seekingalpha.com/news/3366053-consumer-top-5-gainers-losers-of-12-00-pm-06-25-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366053-consumer-top-5-gainers-losers-of-12-00-pm-06-25-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366052\" data-ts=\"1529942306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366052-atlantic-equities-sees-microsoft-azure-topping-100b-in-revenue-in-10-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlantic Equities sees Microsoft Azure topping $100B in revenue in 10 years</a></h4><ul><li>        Atlantic Equities analyst James Cordwell <a href=\"https://www.cnbc.com/2018/06/25/microsofts-azure-to-drive-profits-as-legacy-users-adopt-cloud.html\" target=\"_blank\">rates</a> Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) at Overweight with a $125 price target, a 24% upside to Friday&rsquo;s close.</li><li>               Cordwell says Azure has replaced Windows as Microsoft&rsquo;s key enterprise offering. The analyst expects Azure to hit $115B in revenue in the next decade compared to $185B for AWS.&nbsp;</li><li>               Microsoft shares are&nbsp;<font color='red'>down 1.9%</font>&nbsp;to $98.49. &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366052\" data-linked=\"Atlantic Equities sees Microsoft Azure topping $100B in revenue in 10 years\" data-tweet=\"$MSFT - Atlantic Equities sees Microsoft Azure topping $100B in revenue in 10 years https://seekingalpha.com/news/3366052-atlantic-equities-sees-microsoft-azure-topping-100b-in-revenue-in-10-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3366052-atlantic-equities-sees-microsoft-azure-topping-100b-in-revenue-in-10-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366051\" data-ts=\"1529942122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFTBY\" target=\"_blank\">SFTBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366051-nikkei-softbank-mobile-unit-to-file-for-ipo-soon-july\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nikkei: SoftBank mobile unit to file for IPO soon as July</a></h4><ul>   <li>SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color='red'>-3.4%</font>) will apply to list its Japanese mobile unit in Tokyo <a href=\"https://asia.nikkei.com/Business/Companies/SoftBank-mobile-unit-to-file-for-IPO-as-soon-as-July\" target=\"_blank\">as soon as next month</a>, Nikkei reports.</li>    <li>And the unit could debut on Tokyo's first section by the end of the year.</li>    <li>That would provide capital that SoftBank covets to accelerate its transition into technology investing. While the home wireless business isn't a growth driver, it generates annual cash flow of about &yen;500B (about $4.56B) and posted operating profit of about &yen;680B ($6.18B) for the year ended in March.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365237-softbank-ceo-wants-focus-late-stage-investments-unicorns\" target=\"_blank\">SoftBank CEO wants to focus on late-stage investments, unicorns</a> (Jun. 20 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365041-ft-softbank-add-5b-vision-fund-employees\" target=\"_blank\">FT: SoftBank to add $5B to Vision Fund for employees</a> (Jun. 19 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366051\" data-linked=\"Nikkei: SoftBank mobile unit to file for IPO soon as July\" data-tweet=\"$SFTBY $SFTBF - Nikkei: SoftBank mobile unit to file for IPO soon as July https://seekingalpha.com/news/3366051-nikkei-softbank-mobile-unit-to-file-for-ipo-soon-july?source=tweet\" data-url=\"https://seekingalpha.com/news/3366051-nikkei-softbank-mobile-unit-to-file-for-ipo-soon-july\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366049\" data-ts=\"1529941569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIO\" target=\"_blank\">XBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366049-xenetic-biosciences-doubles-up-on-heavy-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xenetic Biosciences doubles up on heavy volume</a></h4><ul>   <li>Shares in nanocap Xenetic Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a>) are surging today, <font color='green'>up 100%</font> to $5.63.</li>    <li>At just under 6M shares traded, volume is running more than 36 times average.</li>    <li>The company's lead product candidate is XBIO-101, a small molecule immunomodulator and interferon inducer focused on treating progesterone-resistant endometrial cancer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366049\" data-linked=\"Xenetic Biosciences doubles up on heavy volume\" data-tweet=\"$XBIO - Xenetic Biosciences doubles up on heavy volume https://seekingalpha.com/news/3366049-xenetic-biosciences-doubles-up-on-heavy-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3366049-xenetic-biosciences-doubles-up-on-heavy-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366048\" data-ts=\"1529940902\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLDB\" target=\"_blank\">SLDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366048-solid-biosciencesplus-7_6-amid-analyst-praise-for-dmd-approach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid Biosciences +7.6% amid analyst praise for DMD approach</a></h4><ul>   <li>Solid Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a>) is <font color='green'>up 7.6%</font> and hitting record intraday highs following its January IPO, after a pair of new bullish price targets.</li>    <li>Nomura/Instinet has reiterated a Buy based on Solid Bio's potential as a second source in Duchenne muscular dystrophy. It's raised its price target to $57.</li>    <li>Meanwhile, Chardan has a Street-high target of $60 (implying 33% upside) as it sees potential breakthroughs (and a market appearance as soon as 2021) for the company's AAV-based gene therapy. Early results from Sarepta, Pfizer and SLDB support using microdystrophin in DMD, the firm says while urging caution on the data. (h/t Bloomberg)</li>    <li>Shares in <a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a> are <font color='green'>up 86%</font> since IPO.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366048\" data-linked=\"Solid Biosciences +7.6% amid analyst praise for DMD approach\" data-tweet=\"$SLDB - Solid Biosciences +7.6% amid analyst praise for DMD approach https://seekingalpha.com/news/3366048-solid-biosciencesplus-7_6-amid-analyst-praise-for-dmd-approach?source=tweet\" data-url=\"https://seekingalpha.com/news/3366048-solid-biosciencesplus-7_6-amid-analyst-praise-for-dmd-approach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366047\" data-ts=\"1529940878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTNX\" target=\"_blank\">NTNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366047-william-blair-analyst-comments-on-nutanix-partner-contract-federal-momentum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">William Blair analyst comments on Nutanix partner contract, federal momentum</a></h4><ul><li>        William Blair analyst Jason Ader <a href=\"https://www.marketwatch.com/story/nutanix-has-scored-largest-single-deal-ever-analyst-says-2018-06-25\" target=\"_blank\">says</a> his conversations with a Nutanix (NASDAQ:<a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a>) channel partner indicate the partner won a $45M Air Force deal late last month.</li><li>               Ader expects Nutanix to get a $30M to $35M portion &ldquo;split between product revenue and a five-year services agreement.&rdquo;&nbsp;</li><li>               Ader also believes this was Nutanix&rsquo;s &ldquo;largest single deal&rdquo; ever, which shows &ldquo;tremendous momentum&rdquo; in the federal vertical.&nbsp;</li><li>               Nutanix shares are&nbsp;<font color='red'>down 6.1%</font>&nbsp;to $51.03.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366047\" data-linked=\"William Blair analyst comments on Nutanix partner contract, federal momentum\" data-tweet=\"$NTNX - William Blair analyst comments on Nutanix partner contract, federal momentum https://seekingalpha.com/news/3366047-william-blair-analyst-comments-on-nutanix-partner-contract-federal-momentum?source=tweet\" data-url=\"https://seekingalpha.com/news/3366047-william-blair-analyst-comments-on-nutanix-partner-contract-federal-momentum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366044\" data-ts=\"1529940319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MET\" target=\"_blank\">MET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366044-metlife-charged-fraud-massachusetts-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MetLife charged with fraud by Massachusetts: Reuters</a></h4><ul><li>MetLife (NYSE:<a href='https://seekingalpha.com/symbol/MET' title='MetLife, Inc.'>MET</a>)&nbsp;<font color='red'> -1.8%</font>&nbsp;after it's&nbsp; charged with fraud by Massachusetts securities regulator over failure to make pension payments, <a href=\"https://twitter.com/ReutersBiz/status/1011258731135369220\" target=\"_blank\">Reuters reports</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366044\" data-linked=\"MetLife charged with fraud by Massachusetts: Reuters\" data-tweet=\"$MET - MetLife charged with fraud by Massachusetts: Reuters https://seekingalpha.com/news/3366044-metlife-charged-fraud-massachusetts-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3366044-metlife-charged-fraud-massachusetts-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366043\" data-ts=\"1529940313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366043-nasdaq-tumbles-2-mnuchin-clarifies-on-china-tech-crackdown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nasdaq tumbles 2%; Mnuchin clarifies on China tech crackdown</a></h4><ul><li>Global markets were sent reeling early this morning&nbsp;<a href=\"https://seekingalpha.com/news/3365927-futures-fall-trump-targets-chinese-investment\" target=\"_blank\">on reports the</a> Trump administration was set to bar Chinese companies from investing in U.S. technology and block tech exports to that country.</li><li>Treasury Secretary Steven Mnuchin<a href=\"https://www.marketwatch.com/story/mnuchin-investment-restrictions-will-apply-to-all-countries-trying-to-steal-us-technology-not-just-china-2018-06-25\" target=\"_blank\"> is on the wires</a>, calling those reports \"false, fake news.\" Any administration moves, he says, would not be specific to China, but instead target any country trying to steal U.S. technology.</li><li>The Nasdaq (NASDAQ:<a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a>) is now at session lows,&nbsp;<font color='red'>off just over 2%</font>. The S&amp;P 500 (NYSEARCA:<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>) and Dow (NYSEARCA:<a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a>) are each&nbsp;<font color='red'>lower by 1.4%</font>.</li><li>Late in the session in Europe, the Stoxx 600 (NYSEARCA:<a href='https://seekingalpha.com/symbol/FEZ' title='SPDR EURO STOXX 50 ETF'>FEZ</a>) is&nbsp;<font color='red'>down 1.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366043\" data-linked=\"Nasdaq tumbles 2%; Mnuchin clarifies on China tech crackdown\" data-tweet=\"$QQQ $SPY $DIA - Nasdaq tumbles 2%; Mnuchin clarifies on China tech crackdown https://seekingalpha.com/news/3366043-nasdaq-tumbles-2-mnuchin-clarifies-on-china-tech-crackdown?source=tweet\" data-url=\"https://seekingalpha.com/news/3366043-nasdaq-tumbles-2-mnuchin-clarifies-on-china-tech-crackdown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>144&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366042\" data-ts=\"1529939883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIEB\" target=\"_blank\">SIEB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366042-siebertminus-5-on-day-joins-russell-3000-index\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Siebert -5% on day it joins Russell 3000 Index</a></h4><ul><li>Siebert Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a>)<font color='red'> falls 5.2%</font>&nbsp; on volume of 23,113 shares, a little more than half its three-month average daily volume of 41, 785.</li><li>Drop occurs on the same day it<a href=\"https://seekingalpha.com/pr/17197310-siebert-financial-corp-set-join-russell-3000-index\" target=\"_blank\"> joins the Russell 3000 Index </a>as part of the index's annual reconstitution.</li><li>No major news to account for the decline.</li><li>The stock reached its 52-week low of $3.60 on Nov. 16 and its 52-week high of $21.61 on Dec. 20.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366042\" data-linked=\"Siebert -5% on day it joins Russell 3000 Index\" data-tweet=\"$SIEB - Siebert -5% on day it joins Russell 3000 Index https://seekingalpha.com/news/3366042-siebertminus-5-on-day-joins-russell-3000-index?source=tweet\" data-url=\"https://seekingalpha.com/news/3366042-siebertminus-5-on-day-joins-russell-3000-index\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366040\" data-ts=\"1529939692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDMO\" target=\"_blank\">CDMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366040-avid-bioservicesplus-8_5-on-bullish-start-janney\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid Bioservices +8.5% on bullish start at Janney</a></h4><ul>   <li>Avid Bioservices (NASDAQ:<a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a>) is <font color='green'>up 8.5%</font> after getting a Street-high price target of $10 from Janney, starting the company at Buy.</li>    <li>That implies 163% upside from today's already higher price.</li>    <li>Analyst Paul Knight says the company has more than tripled its number of customers in the past 12-18 months and has a number of catalysts ahead, including customer wins and therapeutic approvals. (h/t Bloomberg)</li>    <li>Shares are <font color='red'>down 9%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366040\" data-linked=\"Avid Bioservices +8.5% on bullish start at Janney\" data-tweet=\"$CDMO - Avid Bioservices +8.5% on bullish start at Janney https://seekingalpha.com/news/3366040-avid-bioservicesplus-8_5-on-bullish-start-janney?source=tweet\" data-url=\"https://seekingalpha.com/news/3366040-avid-bioservicesplus-8_5-on-bullish-start-janney\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366036\" data-ts=\"1529938882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGCY\" target=\"_blank\">LGCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366036-legacy-reserves-to-settle-class-action-lawsuits-convert-preferred-units\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Legacy Reserves to settle class action lawsuits, convert preferred units</a></h4><ul>     <li>Legacy Reserves (<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a> <font color='red'>-7.8%</font>) says it entered into a memorandum of understanding to <a href=\"https://seekingalpha.com/pr/17200157-legacy-reserves-lp-signs-memorandum-understanding-regarding-settlement-delaware-merger\" target=\"_blank\">settle class action lawsuits</a> in the Delaware Chancery Court.</li>     <li>As a result, LGCY agrees to convert each outstanding 8% Series A Preferred Unit into the right to receive ~2.92 common shares of New Legacy and convery each outstanding 8% Series B Preferred Unit into the right to receive ~2.9 common shares of New Legacy  (~27.6M total shares).</li><li><a href='https://seekingalpha.com/symbol/LGCYO' title='Legacy Reserves LP Cum Red Perp Pfd Units Series B'>LGCYO</a> <font color='green'>+37.2%</font>, <a href='https://seekingalpha.com/symbol/LGCYP' title='Legacy Reserves LP Cum Red Perp Pfd Units Series A'>LGCYP</a> <font color='green'>+21.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366036\" data-linked=\"Legacy Reserves to settle class action lawsuits, convert preferred units\" data-tweet=\"$LGCY $LGCY $LGCYO - Legacy Reserves to settle class action lawsuits, convert preferred units https://seekingalpha.com/news/3366036-legacy-reserves-to-settle-class-action-lawsuits-convert-preferred-units?source=tweet\" data-url=\"https://seekingalpha.com/news/3366036-legacy-reserves-to-settle-class-action-lawsuits-convert-preferred-units\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366034\" data-ts=\"1529938852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIO\" target=\"_blank\">XBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366034-healthcare-top-5-gainers-losers-of-11-00-06-25-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/25/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='green'>+92%</font>. <a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SPHS' title='Sophiris Bio'>SPHS</a> <font color='red'>-42%</font>. <a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a> <font color='red'>-35%</font>. <a href='https://seekingalpha.com/symbol/ZOM' title='Zomedica Pharmaceuticals Corp.'>OTC:ZOM</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SLNO' title='Soleno Therapeutics, Inc.'>SLNO</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366034\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/25/2018)\" data-tweet=\"$XBIO $XBIO $VLRX - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/25/2018) https://seekingalpha.com/news/3366034-healthcare-top-5-gainers-losers-of-11-00-06-25-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3366034-healthcare-top-5-gainers-losers-of-11-00-06-25-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366030\" data-ts=\"1529938126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXP\" target=\"_blank\">AXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366030-american-expressplus-2-supreme-court-rules-in-favor-on-antitrust-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Express +2% as Supreme court rules in its favor on antitrust case</a></h4><ul><li>American Express (<a href='https://seekingalpha.com/symbol/AXP' title='American Express Company'>AXP</a> <font color='green'>+2.1%</font>) didn't violate federal antitrust laws with restraints the credit card company places on merchants, the <a href=\"https://finance.yahoo.com/news/supreme-court-rules-american-express-141638639.html\" target=\"_blank\">U.S. Supreme Court ruled</a>.</li><li>At issue is American Express's rules that prevent merchants who accept its cards from encouraging consumers to use other credit cards that cost the merchants less in fees.</li><li>The court ruled 5-4 in AXP's favor.</li><li>The Obama administration and a group of states filed the lawsuit against AXP in 2010.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365562-online-retail-rattled-supreme-court-ruling\" target=\"_blank\">Online retail rattled by Supreme Court ruling</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366030\" data-linked=\"American Express +2% as Supreme court rules in its favor on antitrust case\" data-tweet=\"$AXP - American Express +2% as Supreme court rules in its favor on antitrust case https://seekingalpha.com/news/3366030-american-expressplus-2-supreme-court-rules-in-favor-on-antitrust-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3366030-american-expressplus-2-supreme-court-rules-in-favor-on-antitrust-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366029\" data-ts=\"1529938015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CADC\" target=\"_blank\">CADC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366029-on-move-again-china-advanced-construction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">On the move again: China Advanced Construction</a></h4><ul><li>After a share <font color='green'>surge of 27%</font> on Friday, China Advanced Construction Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/CADC' title='China Advanced Construction Materials Group, Inc.'>CADC</a>) is blasting its second stage boosters.</li><li>The stock is starting the week <font color='green'>up 38%</font> to $8.40/share, following an earlier trading halt. Comment on the movement below.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366029\" data-linked=\"On the move again: China Advanced Construction\" data-tweet=\"$CADC - On the move again: China Advanced Construction https://seekingalpha.com/news/3366029-on-move-again-china-advanced-construction?source=tweet\" data-url=\"https://seekingalpha.com/news/3366029-on-move-again-china-advanced-construction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366028\" data-ts=\"1529937730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGFS\" target=\"_blank\">AGFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366028-agrofresh-announces-alliance-del-monte-fresh-produce-n\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AgroFresh announces alliance with Del Monte Fresh Produce N.A.</a></h4><ul>     <li>AgroFresh Solutions (<a href='https://seekingalpha.com/symbol/AGFS' title='AgroFresh Solutions, Inc.'>AGFS</a> <font color='red'>-2.5%</font>) announced a <a href=\"https://seekingalpha.com/pr/17200600-agrofresh-announces-alliance-del-monte-fresh-produce-n-inc\" target=\"_blank\">collaboration agreement</a> with Del Monte Fresh Produce N.A.</li>     <li>The collaboration offers Del Monte, one of the world's leading banana distributors, direct access to RipeLock, AgroFresh's innovative technology for extending yellow life and delivering better quality bananas, inside and out.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366028\" data-linked=\"AgroFresh announces alliance with Del Monte Fresh Produce N.A.\" data-tweet=\"$AGFS - AgroFresh announces alliance with Del Monte Fresh Produce N.A. https://seekingalpha.com/news/3366028-agrofresh-announces-alliance-del-monte-fresh-produce-n?source=tweet\" data-url=\"https://seekingalpha.com/news/3366028-agrofresh-announces-alliance-del-monte-fresh-produce-n\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366026\" data-ts=\"1529936971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOGI\" target=\"_blank\">LOGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366026-goldman-sachs-initiates-logitech-neutral-cites-limited-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs initiates Logitech at Neutral, cites limited upside</a></h4><ul><li>        Goldman Sachs <a href=\"https://www.streetinsider.com/New+Coverage/Goldman+Sachs+Starts+Logitech+Intl+%28LOGI%29+at+Neutral+Citing+Limited+Upside+Potential+to+FY+2019+EPS+Estimate/14337131.html\" target=\"_blank\">initiates</a> Logitech (NASDAQ:<a href='https://seekingalpha.com/symbol/LOGI' title='Logitech International S.A.'>LOGI</a>) with a Neutral rating.</li><li>               Firm cites limited upside potential to FY19 EPS estimates.&nbsp;</li><li>               Logitech shares are&nbsp;<font color='red'>down 1.9%</font>&nbsp;to $43.36.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366026\" data-linked=\"Goldman Sachs initiates Logitech at Neutral, cites limited upside\" data-tweet=\"$LOGI - Goldman Sachs initiates Logitech at Neutral, cites limited upside https://seekingalpha.com/news/3366026-goldman-sachs-initiates-logitech-neutral-cites-limited-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3366026-goldman-sachs-initiates-logitech-neutral-cites-limited-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366022\" data-ts=\"1529936414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMASY\" target=\"_blank\">IMASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366022-inmarsatplus-2_6-on-report-of-eutelsat-takeover-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inmarsat +2.6% on report of Eutelsat takeover interest</a></h4><ul>   <li>Inmarsat (<a href='https://seekingalpha.com/symbol/IMASY' title='Inmarsat Plc. ADR'>OTCPK:IMASY</a>) is <font color='green'>up 2.6%</font> in OTC trading and <font color='green'>up 4%</font> in London on word from Bloomberg that Eutelsat (<a href=\"http://seekingalpha.com/symbol/EUTLY\" target=\"_blank\">EUTLY</a> <font color='green'>+0.7%</font>) is weighing a takeover bid.</li>    <li>That would compete with an ongoing pursuit by EchoStar (NASDAQ:<a href='https://seekingalpha.com/symbol/SATS' title='EchoStar Corporation'>SATS</a>), which on Friday disclosed a near-3% stake in Inmarsat.</li>    <li>Inmarsat <a href=\"https://seekingalpha.com/news/3362793-inmarsat-rejects-takeover-approach-echostar\" target=\"_blank\">said no to EchoStar's approach</a> earlier this month, saying the deal \"significantly undervalued\" the company.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366022\" data-linked=\"Inmarsat +2.6% on report of Eutelsat takeover interest\" data-tweet=\"$IMASY $IMASY $SATS - Inmarsat +2.6% on report of Eutelsat takeover interest https://seekingalpha.com/news/3366022-inmarsatplus-2_6-on-report-of-eutelsat-takeover-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3366022-inmarsatplus-2_6-on-report-of-eutelsat-takeover-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366016\" data-ts=\"1529936392\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBF\" target=\"_blank\">EBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366016-ennis-up-4-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ennis up 4% post Q1 results</a></h4><ul><li>Ennis (<a href='https://seekingalpha.com/symbol/EBF' title='Ennis, Inc.'>EBF</a> <font color='green'>+4.4%</font>) reported Q1 revenue of $93.4M (-1.3% Y/Y) and net earnings increase by 16.13% Y/Y to $9.2M or $0.36.</li><li>Q1 Gross margin&nbsp;<font color='green'>improved by 61 bps</font>&nbsp;to 32.32% Y/Y and operating margin was flat at 13.3%.</li><li>Q1 EBITDA margin&nbsp;<font color='green'>improved by 20 bps</font>&nbsp;to 17.2%</li><li>Company purchased ~38k shares in the quarter at an average price of $17.92 per share.</li><li>&ldquo;We recently completed the integration of our ERP system at our Independent operation and believe we can further optimize its performance. We also recently completed the acquisition of a tag company based in Caledonia, New York and look forward to it contributing to our bottom line in the months to come. We continue to explore strategic opportunities in the acquisition arena as a way to profitably utilize our cash&rdquo;, said Keith Walters, Chairman, President and CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365944-ennis-beats-0_07-beats-revenue\" target=\"_blank\">Ennis beats by $0.07, beats on revenue</a> (June 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366016\" data-linked=\"Ennis up 4% post Q1 results\" data-tweet=\"$EBF - Ennis up 4% post Q1 results https://seekingalpha.com/news/3366016-ennis-up-4-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3366016-ennis-up-4-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366021\" data-ts=\"1529936219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRUS\" target=\"_blank\">CRUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366021-susquehanna-says-cirrus-logic-won-next-airpods\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna says Cirrus Logic won next AirPods</a></h4><ul><li>        Susquehanna <a href=\"https://www.streetinsider.com/Analyst+Comments/Susquehanna+Says+Cirrus+Logic%2C+Inc.+%28CRUS%29+Gets+AirPods2/14338719.html\" target=\"_blank\">says</a> Cirrus Logic (NASDAQ:<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a>) has won the business of Apple&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) next generation of AirPods slated for a fall 2019 release.</li><li>               Firm maintains a Positive rating and a $45 price target. &nbsp;&nbsp;</li><li>               Cirrus Logic shares are&nbsp;<font color='green'>up 7.6%</font>&nbsp;to $40.46.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3366021\" data-linked=\"Susquehanna says Cirrus Logic won next AirPods\" data-tweet=\"$CRUS $CRUS $AAPL - Susquehanna says Cirrus Logic won next AirPods https://seekingalpha.com/news/3366021-susquehanna-says-cirrus-logic-won-next-airpods?source=tweet\" data-url=\"https://seekingalpha.com/news/3366021-susquehanna-says-cirrus-logic-won-next-airpods\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366018\" data-ts=\"1529935940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366018-amazon-roundup-whole-foods-discounts-nationwide-fired-workers-can-now-appeal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon roundup: Whole Foods discounts nationwide, fired workers can now appeal</a></h4><ul><li>        Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) <a href=\"https://seekingalpha.com/pr/17199973-savings-prime-members-whole-foods-market-available-stores-nationwide-starting-june-27\" target=\"_blank\">rolls out</a> Whole Foods discounts for Prime members nationwide.</li><li>               Prime members get 10% off certain sale items and other discounts at all Whole Foods stores.&nbsp;</li><li>                  The rollout will be complete by June 27.    </li><li>               Prime members in certain cities can get the same deals with grocery delivery. Participating cities include Atlanta, Austin, Los Angeles, San Diego, and Denver.&nbsp;</li><li>               In other Amazon news, company workers facing dismissal now <a href=\"https://www.bloomberg.com/news/articles/2018-06-25/amazon-workers-facing-firing-can-appeal-to-a-jury-of-their-co-workers\" target=\"_blank\">have the option</a> of appealing to a jury of colleagues.&nbsp;</li><li>                  Amazon shares are&nbsp;<font color='red'>down 2.4%</font>&nbsp;to $1,673.98.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3366018\" data-linked=\"Amazon roundup: Whole Foods discounts nationwide, fired workers can now appeal\" data-tweet=\"$AMZN - Amazon roundup: Whole Foods discounts nationwide, fired workers can now appeal https://seekingalpha.com/news/3366018-amazon-roundup-whole-foods-discounts-nationwide-fired-workers-can-now-appeal?source=tweet\" data-url=\"https://seekingalpha.com/news/3366018-amazon-roundup-whole-foods-discounts-nationwide-fired-workers-can-now-appeal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366017\" data-ts=\"1529935751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RBBN\" target=\"_blank\">RBBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366017-ribbon-communications-to-acquire-edgewater-networks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ribbon Communications to acquire Edgewater Networks</a></h4><ul>     <li>Ribbon Communications (<a href='https://seekingalpha.com/symbol/RBBN' title='Ribbon Communications Inc.'>RBBN</a> <font color='red'>-0.9%</font>) to <a href=\"https://seekingalpha.com/pr/17200291-ribbon-communications-signs-agreement-acquire-edgewater-networks-inc\" target=\"_blank\">acquire</a> Edgewater Networks for $110M.</li>     <li>Edgewater Networks is a market leader in Network Edge Orchestration for the small and medium enterprise and Unified Communications market.</li>     <li>Edgewater Networks revenue was $64M (+28% Y/Y) in 2017 and adj. EBITDA was $4M (+98% Y/Y) in 2017.</li>     <li>The transaction is expected to close in the Q318. The transaction is expected to be immediately accretive to Ribbon&rsquo;s Adjusted EBITDA and Non-GAAP EPS post-closing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3366017\" data-linked=\"Ribbon Communications to acquire Edgewater Networks\" data-tweet=\"$RBBN - Ribbon Communications to acquire Edgewater Networks https://seekingalpha.com/news/3366017-ribbon-communications-to-acquire-edgewater-networks?source=tweet\" data-url=\"https://seekingalpha.com/news/3366017-ribbon-communications-to-acquire-edgewater-networks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366012\" data-ts=\"1529935316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCL\" target=\"_blank\">CCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366012-carnival-tumbles-8_5-after-soft-guidance-cruise-line-industry-falls-alongside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carnival tumbles 8.5% after soft guidance, cruise line industry falls alongside</a></h4><ul><li>Carnival (<a href='https://seekingalpha.com/symbol/CCL' title='Carnival Corporation'>CCL</a> <font color='red'>-8.5%</font>) topped estimates, but trimmed its full-year EPS outlook to $4.15-$4.25 from $4.20-$4.40. Among the issues are higher fuel costs and changes in forex rates.</li><li>The company did lift its net revenue yield to about 3% from 2.5%, but the Street was at 3.15%.</li><li>The <a href=\"http://www.carnivalcorp.com\" target=\"_blank\">conference call</a> is just underway.</li><li>Norwegian Cruise (<a href='https://seekingalpha.com/symbol/NCLH' title='Norwegian Cruise Line Holdings Ltd.'>NCLH</a> <font color='red'>-5.1%</font>), Royal Caribbean (<a href='https://seekingalpha.com/symbol/RCL' title='Royal Caribbean Cruises Ltd.'>RCL</a> <font color='red'>-4.5%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365992-carnival-beats-0_09-beats-revenue\" target=\"_blank\">Carnival beats by $0.09, beats on revenue</a> (June 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3366012\" data-linked=\"Carnival tumbles 8.5% after soft guidance, cruise line industry falls alongside\" data-tweet=\"$CCL $CCL $NCLH - Carnival tumbles 8.5% after soft guidance, cruise line industry falls alongside https://seekingalpha.com/news/3366012-carnival-tumbles-8_5-after-soft-guidance-cruise-line-industry-falls-alongside?source=tweet\" data-url=\"https://seekingalpha.com/news/3366012-carnival-tumbles-8_5-after-soft-guidance-cruise-line-industry-falls-alongside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366005\" data-ts=\"1529934205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALRM\" target=\"_blank\">ALRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366005-alarm-complus-4_3-on-raymond-james-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alarm.com +4.3% on Raymond James upgrade</a></h4><ul><li>           Raymond James <a href=\"https://www.streetinsider.com/Upgrades/Raymond+James+Upgrades+Alarm.com+%28ALRM%29+to+Strong+Buy/14337758.html\" target=\"_blank\">upgrades</a> Alarm.com (NASDAQ:<a href='https://seekingalpha.com/symbol/ALRM' title='Alarm.com'>ALRM</a>) to Strong Buy. </li><li> Alarm.com shares are&nbsp;<font color='green'>up 4.3%</font>&nbsp;to $39.20.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3366005\" data-linked=\"Alarm.com +4.3% on Raymond James upgrade\" data-tweet=\"$ALRM - Alarm.com +4.3% on Raymond James upgrade https://seekingalpha.com/news/3366005-alarm-complus-4_3-on-raymond-james-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3366005-alarm-complus-4_3-on-raymond-james-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366003\" data-ts=\"1529934067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GKOS\" target=\"_blank\">GKOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366003-glaukos-wins-fda-approval-for-treatment-managing-glaucoma-patients-iop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glaukos wins FDA approval for treatment managing glaucoma patients\u2019 IOP</a></h4><ul>     <li>Glaukos (<a href='https://seekingalpha.com/symbol/GKOS' title='Glaukos'>GKOS</a> <font color='green'>+5.7%</font>) opens higher after <a href=\"https://seekingalpha.com/pr/17200018-glaukos-announces-fda-approval-istent-inject-trabecular-micro-bypass-system\" target=\"_blank\">receiving FDA approval</a> for its iStent inject Trabecular Micro-Bypass System indicated for the reduction of intraocular pressure in primary open-angle glaucoma patients undergoing concomitant cataract surgery.</li>     <li>The FDA approval is based on pivotal trial data showing the iStent inject achieved a statistically       significant reduction in unmedicated diurnal IOP in patients undergoing cataract surgery at 24 months.</li>     <li>GKOS says it plans to begin initial commercial launch activities for the iStent inject later in Q3.</li></ul><div class=\"tiny-share-widget\" data-id=\"3366003\" data-linked=\"Glaukos wins FDA approval for treatment managing glaucoma patients\u2019 IOP\" data-tweet=\"$GKOS - Glaukos wins FDA approval for treatment managing glaucoma patients\u2019 IOP https://seekingalpha.com/news/3366003-glaukos-wins-fda-approval-for-treatment-managing-glaucoma-patients-iop?source=tweet\" data-url=\"https://seekingalpha.com/news/3366003-glaukos-wins-fda-approval-for-treatment-managing-glaucoma-patients-iop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3366002\" data-ts=\"1529933989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDB\" target=\"_blank\">MDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3366002-mongodbminus-5_5-on-planned-private-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MongoDB -5.5% on planned private note offering</a></h4><ul><li>        MongoDB (NASDAQ:<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a>) <a href=\"https://seekingalpha.com/pr/17200286-mongodb-announces-proposed-private-offering-200-million-convertible-senior-notes\" target=\"_blank\">announces plans</a> to offer $200M in convertible senior notes due 2024 in a private offering.</li><li>                  Initial purchasers have the right to an additional $30M in notes.    </li><li>                  MongoDB shares are&nbsp;<font color='red'>down 5.5%</font>&nbsp;to $53.82.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3366002\" data-linked=\"MongoDB -5.5% on planned private note offering\" data-tweet=\"$MDB - MongoDB -5.5% on planned private note offering https://seekingalpha.com/news/3366002-mongodbminus-5_5-on-planned-private-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3366002-mongodbminus-5_5-on-planned-private-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365995\" data-ts=\"1529933030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRM\" target=\"_blank\">XRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365995-premarket-gainers-of-9-05-6-25-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (6/25/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/XRM' title='Xerium Technologies, Inc.'>XRM</a> <font color='green'>+101%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3365973-xerium-tech-bought-andritz-ag-13_50-share\" target=\"_blank\">acquired</a> by Andritz AG.</li>     <li><a href='https://seekingalpha.com/symbol/LGCYO' title='Legacy Reserves LP Cum Red Perp Pfd Units Series B'>LGCYO</a> <font color='green'>+46%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a> <font color='green'>+44%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/GTN' title='Gray Television, Inc.'>GTN</a> <font color='green'>+17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3365956-gray-television-buying-raycom-media-3_6b\" target=\"_blank\">buying</a> Raycom Media for $3.6B.</li>     <li><a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a> <font color='green'>+10%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a> <font color='green'>+10%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17200265-avid-bioservices-added-russell-3000-index-russell-2000-index\" target=\"_blank\">being added</a> to Russell 3000 and Russell 2000 index.</li>     <li><a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17200298-boxlight-announces-acquisition-qwizdom\" target=\"_blank\">acquisition</a> of Qwizdom.</li>     <li><a href='https://seekingalpha.com/symbol/SXE' title='Southcross Energy Partners'>SXE</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='green'>+5%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3365983-clps-plus-5-percent-premarket-investment-lihong-financial-information\" target=\"_blank\">investment</a> in Lihong Financial Information.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365995\" data-linked=\"Premarket Gainers as of 9:05 am (6/25/2018)\" data-tweet=\"$XRM $XRM $LGCYO - Premarket Gainers as of 9:05 am (6/25/2018) https://seekingalpha.com/news/3365995-premarket-gainers-of-9-05-6-25-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365995-premarket-gainers-of-9-05-6-25-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365994\" data-ts=\"1529932955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLRX\" target=\"_blank\">VLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365994-valeritasplus-48-study-shows-v-go-clinical-benefits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeritas +48% as study shows V-Go clinical benefits</a></h4><ul>     <li>Valeritas (NASDAQ:<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a>) <font color='green'>+48.6%</font> premarket after announcing <a href=\"https://seekingalpha.com/pr/17200034-valeritas-enable-study-demonstrates-significant-clinical-benefits-v-go-patients-type-2\" target=\"_blank\">positive results</a> in a study of its V-Go wearable insulin delivery device in type 2 Diabetes patients who switched from insulin pens and syringes.</li>     <li>&ldquo;The largest study of V-Go patients to date has demonstrated that regardless of baseline insulin dose or duration of diabetes, patients who switched to V-Go significantly lowered their blood glucose,\" the company says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365994\" data-linked=\"Valeritas +48% as study shows V-Go clinical benefits\" data-tweet=\"$VLRX - Valeritas +48% as study shows V-Go clinical benefits https://seekingalpha.com/news/3365994-valeritasplus-48-study-shows-v-go-clinical-benefits?source=tweet\" data-url=\"https://seekingalpha.com/news/3365994-valeritasplus-48-study-shows-v-go-clinical-benefits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365991\" data-ts=\"1529932631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365991-ciena-named-top-optical-pick-morgan-stanley-sharesplus-2_9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ciena named top optical pick at Morgan Stanley; shares +2.9%</a></h4><ul>   <li>Ciena (NASDAQ:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) is <font color='green'>up 2.9%</font> with Morgan Stanley giving it top optical pick status in an upgrade to Overweight.</li>    <li>The company's <a href=\"https://seekingalpha.com/article/4178833-ciena-corporation-2018-q2-results-earnings-call-slides\" target=\"_blank\">aiming for adjusted gross margin</a> in the low 40s in Q3, and long-term adjusted operating margin of 15%, but analyst Meta Marshall thinks those targets are too high; if margins got closer to the goal then the stock would hit a bull case of $40 rather than Morgan Stanley's new price target of $30, implying 21% upside. (h/t Bloomberg)</li>    <li>Shares have <font color='green'>risen 18.8%</font> YTD.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3365991\" data-linked=\"Ciena named top optical pick at Morgan Stanley; shares +2.9%\" data-tweet=\"$CIEN - Ciena named top optical pick at Morgan Stanley; shares +2.9% https://seekingalpha.com/news/3365991-ciena-named-top-optical-pick-morgan-stanley-sharesplus-2_9?source=tweet\" data-url=\"https://seekingalpha.com/news/3365991-ciena-named-top-optical-pick-morgan-stanley-sharesplus-2_9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365990\" data-ts=\"1529932404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPHS\" target=\"_blank\">SPHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365990-premarket-losers-of-9-05-06-25-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (06/25/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SPHS' title='Sophiris Bio'>SPHS</a>&nbsp;<font color='red'>-46%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3365981-sophiris-minus-49_6-percent-halting-trial-patient-death\" target=\"_blank\">halting trial</a> on patient death.</li>     <li><a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a>&nbsp;<font color='red'>-35%</font>&nbsp;as pancreatic cancer treatment <a href=\"https://seekingalpha.com/news/3365969-merrimack-pharma-minus-31-percent-pancreatic-cancer-treatment-fails-meet-goals\" target=\"_blank\">fails</a> to meet goals.</li>     <li><a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>&nbsp;<font color='red'>-8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a>&nbsp;<font color='red'>-8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/SOGO' title='Sogou'>SOGO</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17199941-sogou-announces-resignation-chief-operating-officer\" target=\"_blank\">resignation</a> of COO.</li>     <li><a href='https://seekingalpha.com/symbol/SLNO' title='Soleno Therapeutics, Inc.'>SLNO</a>&nbsp;<font color='red'>-7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc'>IQ</a>&nbsp;<font color='red'>-6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/HUYA' title='Huya Broadcasting'>HUYA</a>&nbsp;<font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365990\" data-linked=\"Premarket Losers as of 9:05 am (06/25/2018)\" data-tweet=\"$SPHS $SPHS $MACK - Premarket Losers as of 9:05 am (06/25/2018) https://seekingalpha.com/news/3365990-premarket-losers-of-9-05-06-25-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365990-premarket-losers-of-9-05-06-25-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365981\" data-ts=\"1529930531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPHS\" target=\"_blank\">SPHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365981-sophirisminus-49_6-after-halting-trial-on-patient-death\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sophiris -49.6% after halting trial on patient death</a></h4><ul><li>Sophiris (NASDAQ:<a href='https://seekingalpha.com/symbol/SPHS' title='Sophiris Bio'>SPHS</a>) <a href=\"https://endpts.com/sudden-death-forces-sophiris-to-halt-followup-therapy-in-prostate-cancer-study/\" target=\"_blank\">halts its dosing schedule</a> for its Phase IIb prostate cancer study due to a patient dying shortly after receiving a second dose.</li><li>The company didn&rsquo;t provide details on what killed the patient.</li><li>Sophiris shares&nbsp;<font color='red'>plunge 49.6%</font>&nbsp;premarket to $1.88.</li><li>Update to include a link to the company's <a href=\"https://www.prnewswire.com/news-releases/sophiris-bio-reports-top-line-interim-safety-and-biopsy-findings-for-its-phase-2b-clinical-trial-of-topsalysin-in-localized-prostate-cancer-300671338.html\" target=\"_blank\">press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365981\" data-linked=\"Sophiris -49.6% after halting trial on patient death\" data-tweet=\"$SPHS - Sophiris -49.6% after halting trial on patient death https://seekingalpha.com/news/3365981-sophirisminus-49_6-after-halting-trial-on-patient-death?source=tweet\" data-url=\"https://seekingalpha.com/news/3365981-sophirisminus-49_6-after-halting-trial-on-patient-death\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365979\" data-ts=\"1529930085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365979-nomura-downgrades-intel-on-ceo-search-intcminus-2_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura downgrades Intel on CEO search; INTC -2.3%</a></h4><ul><li>           Nomura Instinet <a href=\"https://www.cnbc.com/2018/06/25/nomura-instinet-downgrades-intel-due-to-lack-of-leadership.html\" target=\"_blank\">downgrades</a> Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) from Buy to Neutral on concerns about the company&rsquo;s CEO search. Price target drops from $60 to $55, a 5% upside to Friday&rsquo;s close. </li><li> Analyst Romit Shah says Brian Krzanich&rsquo;s &ldquo;departure is disappointing on multiple levels&rdquo; and thinks the &ldquo;lack of leadership will only add to the already growing uncertainty about Intel&rsquo;s long-term franchise.&rdquo; </li><li> The analyst hopes Intel appoints an external candidate &ldquo;such as Hock Tan at Broadcom or Sanjay Jha from GlobalFoundries&rdquo; to increase shareholder value and help Intel deal with its problems moving to is 10nm chip manufacturing process. </li><li> Intel shares are&nbsp;<font color='red'>down 2.3%</font>&nbsp;premarket to $51.30.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3365506-intel-plus-2_1-percent-ceo-resignation\" target=\"_blank\">Intel +2.1% on CEO resignation</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365979\" data-linked=\"Nomura downgrades Intel on CEO search; INTC -2.3%\" data-tweet=\"$INTC - Nomura downgrades Intel on CEO search; INTC -2.3% https://seekingalpha.com/news/3365979-nomura-downgrades-intel-on-ceo-search-intcminus-2_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3365979-nomura-downgrades-intel-on-ceo-search-intcminus-2_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365976\" data-ts=\"1529929546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZFGN\" target=\"_blank\">ZFGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365976-zafgen-up-7_5-after-study-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zafgen up 7.5% after study results</a></h4><ul><li>The Phase 2 trial of ZGN-1061,&nbsp;designed to demonstrate proof-of-concept efficacy and safety in patients with type 2 diabetes and establish a minimally effective dose, met all of its primary enpoints at the 0.9 mg does, and 12-week data demonstrated a favorable safety and tolerability profile.</li><li>A <a href=\"https://zafgen.gcs-web.com/events-and-presentations\" target=\"_blank\">conference call </a>is underway.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17199796-zafgen-announces-positive-full-results-phase-2-proof-concept-trial-zgnminus-1061-patients\" target=\"_blank\">Press Release</a></li><li><a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a>&nbsp;<font color='green'>+7.5%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3365976\" data-linked=\"Zafgen up 7.5% after study results\" data-tweet=\"$ZFGN - Zafgen up 7.5% after study results https://seekingalpha.com/news/3365976-zafgen-up-7_5-after-study-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3365976-zafgen-up-7_5-after-study-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365969\" data-ts=\"1529928464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MACK\" target=\"_blank\">MACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365969-merrimack-pharmaminus-31-pancreatic-cancer-treatment-fails-to-meet-goals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merrimack Pharma -31% as pancreatic cancer treatment fails to meet goals</a></h4><ul>     <li>Merrimack Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a>) <font color='red'>-31.3%</font> premarket upon resumption of trade after announcing that top-line results from a trial of its pancreatic cancer treatment <a href=\"https://seekingalpha.com/pr/17200096-merrimack-announces-top-line-results-randomized-phase-2-trial-mmminus-141-front-line\" target=\"_blank\">failed to meet primary or secondary endpoints</a>.</li>     <li>MACK's CARRIE study was a Phase 2 trial evaluating the addition of MM-141 (istiratumab) to current treatments for patients with previously untreated metastatic pancreatic cancer and high serum levels of free Insulin-like Growth Factor-1.</li>     <li>MACK says it will not devote more resources to the development of MM-141, but will continue with its MM-121 and MM-310 clinical programs, with data expected later in 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365969\" data-linked=\"Merrimack Pharma -31% as pancreatic cancer treatment fails to meet goals\" data-tweet=\"$MACK - Merrimack Pharma -31% as pancreatic cancer treatment fails to meet goals https://seekingalpha.com/news/3365969-merrimack-pharmaminus-31-pancreatic-cancer-treatment-fails-to-meet-goals?source=tweet\" data-url=\"https://seekingalpha.com/news/3365969-merrimack-pharmaminus-31-pancreatic-cancer-treatment-fails-to-meet-goals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365967\" data-ts=\"1529928143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365967-lexicon-pharmaplus-3-on-diabetes-drug-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon Pharma +3% on diabetes drug results</a></h4><ul><li>Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) <font color='green'>+3%</font> premarket after <a href=\"https://seekingalpha.com/pr/17199845-lexicon-pharmaceuticals-announces-positive-52-week-results-sotagliflozin-intandem1-study\" target=\"_blank\">announcing</a> positive 52-week results from the Phase 3 inTandem1 study for sotagliflozin in adults with type 1 diabetes.</li><li>In the North American study, administration of sotagliflozin 200 mg or 400 mg in combination with maximally tolerated standard of care insulin therapy resulted in statistically significant reductions in A1C levels and weight compared to optimized insulin alone.</li><li>A lower incidence of severe hypoglycemia was observed with sotagliflozin 200 mg and 400 mg compared to placebo.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365967\" data-linked=\"Lexicon Pharma +3% on diabetes drug results\" data-tweet=\"$LXRX - Lexicon Pharma +3% on diabetes drug results https://seekingalpha.com/news/3365967-lexicon-pharmaplus-3-on-diabetes-drug-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3365967-lexicon-pharmaplus-3-on-diabetes-drug-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365963\" data-ts=\"1529927772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365963-first-solar-upgraded-to-buy-baml-on-most-bullish-irs-interpretation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar upgraded to Buy at BAML on &#39;most bullish&#39; IRS interpretation</a></h4><ul>     <li>First Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a>) <font color='green'>+3.8%</font> premarket as BofA Merrill Lynch <a href=\"https://thefly.com/thestreet/realmoney/index.php/FSLR%3bCSIQ%3bSUNEQ%3bTSL%3bJASO%3bYGE%3bSPWRid2749671/FSLR%3bCSIQ%3bSUNEQ%3bTSL%3bJASO%3bYGE%3bSPWR-First-Solar-upgraded-to-Buy-on-most-bullish-possible-IRS-guide-at-BofAMerrill\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $63 price target, citing <a href=\"https://seekingalpha.com/news/3365913-favorable-irs-ruling-surprise-gift-solar-developers\" target=\"_blank\">latest IRS tax  guidance</a> allowing as much as a four-year ITC extension on solar  projects, which analyst Julien Dumoulin-Smith says was \"the most bullish interpretation IRS could have released.\"</li>     <li>The IRS guidance is likely worth at least $50B to his prior cumulative capex expectations for the sector through 2023, Dumoulin-Smith says; although less confident of a module price recovery, he sees prospects for more U.S.-bound projects.</li>     <li>Credit Suisse said Friday that the IRS ruling is positive for solar developers with a strong pipeline, including FSLR and NextEra Energy (NYSE:<a href='https://seekingalpha.com/symbol/NEE' title='NextEra Energy, Inc.'>NEE</a>), while the impact on residential and distributed generators should be relatively  smaller given shorter construction times but still positive for Sunrun (NASDAQ:<a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a>), SunPower (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a>) and Vivint Solar (NYSE:<a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a>); the ruling is seen as negative for solar manufacturers such as Jinko Solar (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>), JA&nbsp;Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/JASO' title='JA Solar Holdings, Co., Ltd.'>JASO</a>) and Canadian Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a>).</li><li>ETFs: <a href='https://seekingalpha.com/symbol/TAN' title='Invesco Solar Portfolio ETF'>TAN</a>, <a href='https://seekingalpha.com/symbol/KWT' title='VanEck Vectors Solar Energy ETF'>KWT</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3365963\" data-linked=\"First Solar upgraded to Buy at BAML on &#39;most bullish&#39; IRS interpretation\" data-tweet=\"$FSLR $FSLR $NEE - First Solar upgraded to Buy at BAML on &#39;most bullish&#39; IRS interpretation https://seekingalpha.com/news/3365963-first-solar-upgraded-to-buy-baml-on-most-bullish-irs-interpretation?source=tweet\" data-url=\"https://seekingalpha.com/news/3365963-first-solar-upgraded-to-buy-baml-on-most-bullish-irs-interpretation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365959\" data-ts=\"1529926983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOG\" target=\"_blank\">HOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365959-harley-davidson-sees-eu-tariffs-adding-2200-to-average-motorcycle-cost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harley-Davidson sees EU tariffs adding $2,200 to average motorcycle cost</a></h4><ul>     <li>Harley-Davidson (NYSE:<a href='https://seekingalpha.com/symbol/HOG' title='Harley-Davidson, Inc.'>HOG</a>) <font color='red'>-2.7%</font> premarket after saying it expects European Union tariffs will <a href=\"https://www.sec.gov/Archives/edgar/data/793952/000079395218000038/a8-kitem701tariffdisclosur.htm\" target=\"_blank\">add ~$2,200 to the cost</a> of the average motorcycle exported from the U.S. to the EU.</li>     <li>But HOG says it will not raise retail prices or wholesale prices to dealers to cover the costs of the tariffs, because it \"believes the tremendous cost increase, if passed onto its dealers and retail customers, would have an immediate and lasting detrimental impact to its business in the region, reducing customer access to  Harley-Davidson products and negatively impacting the sustainability of  its dealers&rsquo; businesses.\"</li>     <li>HOG expects the tariffs to cost $30M-$45M over the rest of this year and could cost $90M-$100M on a full-year basis.</li><li>HOG plans to shift production of motorcycles for EU destinations from the U.S. to its  international facilities to avoid the tariff burden; it expects the ramp-up will require incremental investment and could take at least 9-18 months to be  fully complete.</li><li><a href=\"https://seekingalpha.com/news/3365879-harley-davidson-says-eu-tariffs-likely-cause-price-hikes-fall\" target=\"_blank\">Earlier</a>: Harley-Davidson says EU tariffs likely to cause price hikes this fall (June 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365959\" data-linked=\"Harley-Davidson sees EU tariffs adding $2,200 to average motorcycle cost\" data-tweet=\"$HOG - Harley-Davidson sees EU tariffs adding $2,200 to average motorcycle cost https://seekingalpha.com/news/3365959-harley-davidson-sees-eu-tariffs-adding-2200-to-average-motorcycle-cost?source=tweet\" data-url=\"https://seekingalpha.com/news/3365959-harley-davidson-sees-eu-tariffs-adding-2200-to-average-motorcycle-cost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365956\" data-ts=\"1529926629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTN\" target=\"_blank\">GTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365956-gray-television-buying-raycom-media-for-3_6b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gray Television buying Raycom Media for $3.6B</a></h4><ul><li>Gray Television (NYSE:<a href='https://seekingalpha.com/symbol/GTN' title='Gray Television, Inc.'>GTN</a>) will transform from a small, regional broadcaster into one with nationwide scale.</li><li>Upon closing Raycom President and CEO Pat LaPlatney will become president and co-CEO at Gray. Closing is expected in Q4.</li><li>Terms: $2.85B in cash, $650M in new preferred stock, and 11.5M shares of GTN common stock. The deal price represents about 7.5x a blended average of Raycom's anticipated 2017/2018 cash flow.</li><li><a href=\"http://www.gray.tv\" target=\"_blank\">Conference call at 9 ET</a></li><li>Source: <a href=\"https://seekingalpha.com/pr/17200097-gray-raycom-combine-3_6-billion-transaction\" target=\"_blank\">Press Release</a></li><li>Shares flat premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3365956\" data-linked=\"Gray Television buying Raycom Media for $3.6B\" data-tweet=\"$GTN - Gray Television buying Raycom Media for $3.6B https://seekingalpha.com/news/3365956-gray-television-buying-raycom-media-for-3_6b?source=tweet\" data-url=\"https://seekingalpha.com/news/3365956-gray-television-buying-raycom-media-for-3_6b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365952\" data-ts=\"1529925746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWLO\" target=\"_blank\">TWLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365952-twilio-initiated-27-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twilio initiated at 27% upside</a></h4><ul><li>        Piper Jaffray <a href=\"https://www.streetinsider.com/Analyst+Comments/Piper+Jaffray+Starts+Twilio+%28TWLO%29+at+Overweight/14337108.html\" target=\"_blank\">initiates</a> Twilio (NYSE:<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a>) at an Overweight rating with a $70 price target.</li><li>               Target represents a 27% upside to Friday&rsquo;s close.&nbsp;</li><li>               Twilio shares are&nbsp;<font color='green'>up 0.9%</font>&nbsp;premarket to $55.75.&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3365952\" data-linked=\"Twilio initiated at 27% upside\" data-tweet=\"$TWLO - Twilio initiated at 27% upside https://seekingalpha.com/news/3365952-twilio-initiated-27-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3365952-twilio-initiated-27-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365950\" data-ts=\"1529925243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIDU\" target=\"_blank\">BIDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365950-baiduminus-2_8-on-cdr-listing-consideration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baidu -2.8% on CDR listing consideration</a></h4><ul><li>        Baidu (NASDAQ:<a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a>) is <a href=\"https://seekingalpha.com/filing/4077647\" target=\"_blank\">evaluating</a> a potential offering and listing of Chinese depository receipts in China.</li><li>               Any CDR offered will represent new Class A ordinary shares.&nbsp;</li><li>                  Baidu shares are&nbsp;<font color='red'>down 2.8%</font>&nbsp;premarket to $251.82.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3365950\" data-linked=\"Baidu -2.8% on CDR listing consideration\" data-tweet=\"$BIDU - Baidu -2.8% on CDR listing consideration https://seekingalpha.com/news/3365950-baiduminus-2_8-on-cdr-listing-consideration?source=tweet\" data-url=\"https://seekingalpha.com/news/3365950-baiduminus-2_8-on-cdr-listing-consideration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365946\" data-ts=\"1529924799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365946-pivotal-rings-register-on-kroger-shares-down-1_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pivotal rings the register on Kroger; shares down 1.7%</a></h4><ul><li>There's insufficient upside from here following the big post-earnings move higher in Kroger (NYSE:<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a>), says analyst Ajay Jain, downgrading to Hold from Buy.</li><li>More good news could be coming, but the company's store optimization process also carries near-term risk, says Jain, trimming his price target to $30 from $31.</li><li>Shares&nbsp;<font color='red'>down 1.7%&nbsp;</font>premarket to $29.18.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3365946\" data-linked=\"Pivotal rings the register on Kroger; shares down 1.7%\" data-tweet=\"$KR - Pivotal rings the register on Kroger; shares down 1.7% https://seekingalpha.com/news/3365946-pivotal-rings-register-on-kroger-shares-down-1_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3365946-pivotal-rings-register-on-kroger-shares-down-1_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":72,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}